Connect public, paid and private patent data with Google Patents Public Datasets

Marker delivery device with releasable plug

Download PDF

Info

Publication number
US20040236213A1
US20040236213A1 US10753694 US75369404A US2004236213A1 US 20040236213 A1 US20040236213 A1 US 20040236213A1 US 10753694 US10753694 US 10753694 US 75369404 A US75369404 A US 75369404A US 2004236213 A1 US2004236213 A1 US 2004236213A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
marker
delivery
device
fibrous
plug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10753694
Inventor
Michael Jones
Paul Lubock
John Merritt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SenoRx Inc
Original Assignee
SenoRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B19/54
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00637Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00898Material properties expandable upon contact with fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • A61B2090/3908Soft tissue, e.g. breast tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/392Radioactive markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925Markers, e.g. radio-opaque or breast lesions markers ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3954Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3987Applicators for implanting markers

Abstract

The invention is directed to marker delivery devices and methods of using such devices. The delivery devices embodying features of the invention include a delivery cannula with a discharge opening and a releasable plug disposed in the inner lumen of the delivery cannula so as to at least partially occlude the discharge opening. The releasable plug prevents ingress of tissue, body fluids and the like into the bore of the tube, and prevents the premature discharge of any markers proximal to the releasable plug from passing through the discharge opening before the distal end of the cannula is properly positioned at a desired location within a patient's body. The releasable plug preferably has an MRI detectable element. Preferably, at least one remotely detectable marker mass is provided in the inner lumen of the cannula proximal to the releasable plug.

Description

    RELATED APPLICATIONS
  • [0001]
    This application is a continuation-in-part of application Ser. No. 10/444,770, filed on May 23, 2003 which is incorporated herein by reference in its entirety and from which priority is claimed.
  • FIELD OF THE INVENTION
  • [0002]
    The invention is generally directed to devices and methods for the delivery of remotely detectable markers to a desired location within a patient's body. In particular, the invention is directed to devices, and methods configured to retain a remotely detectable marker within a delivery device before delivery to a desired intracorporeal location.
  • BACKGROUND OF THE INVENTION
  • [0003]
    In diagnosing and treating certain medical conditions, it is often desirable to mark a suspicious body site for the subsequent taking of a biopsy specimen, for delivery of medicine, radiation, or other treatment, for the relocation of a site from which a biopsy specimen was taken, or at which some other procedure was performed. As is known, obtaining a tissue sample by biopsy and the subsequent examination are typically employed in the diagnosis of cancers and other malignant tumors, or to confirm that a suspected lesion or tumor is not malignant. The information obtained from these diagnostic tests and/or examinations is frequently used to devise a therapeutic plan for the appropriate surgical procedure or other course of treatment.
  • [0004]
    In many instances, the suspicious tissue to be sampled is located in a subcutaneous site, such as inside a human breast. To minimize surgical intrusion into a patient's body, it is often desirable to insert a small instrument, such as a biopsy needle, into the body for extracting the biopsy specimen while imaging the procedure using fluoroscopy, ultrasonic imaging, x-rays, magnetic resonance imaging (MRI) or any other suitable form of imaging technique. Examination of tissue samples taken by biopsy is of particular significance in the diagnosis and treatment of breast cancer. In the ensuing discussion, the biopsy and treatment site described will generally be the human breast, although the invention is suitable for marking biopsy sites in other parts of the human and other mammalian body as well.
  • [0005]
    Periodic physical examination of the breasts and mammography are important for early detection of potentially cancerous lesions. In mammography, the breast is compressed between two plates while specialized x-ray images are taken. If an abnormal mass in the breast is found by physical examination or mammography, ultrasound may be used to determine whether the mass is a solid tumor or a fluid-filled cyst. Solid masses are usually subjected to some type of tissue biopsy to determine if the mass is cancerous.
  • [0006]
    If a solid mass or lesion is large enough to be palpable, a tissue specimen can be removed from the mass by a variety of techniques, including but not limited to open surgical biopsy, a technique known as Fine Needle Aspiration Biopsy (FNAB) and instruments characterized as “vacuum assisted large core biopsy devices”.
  • [0007]
    If a solid mass of the breast is small and non-palpable (e.g., the type typically discovered through mammography), a vacuum assisted large core biopsy procedure is usually used. In performing a stereotactic biopsy of a breast, the patient lies on a special biopsy table with her breast compressed between the plates of a mammography apparatus and two separate x-rays or digital video views are taken from two different points of view. A computer calculates the exact position of the lesion as well as depth of the lesion within the breast. Thereafter, a mechanical stereotactic apparatus is programmed with the coordinates and depth information calculated by the computer, and such apparatus is used to precisely advance the biopsy needle into the small lesion. The stereotactic technique may be used to obtain histologic specimens. Usually at least five separate biopsy specimens are obtained from locations around the small lesion as well as one from the center of the lesion.
  • [0008]
    The available treatment options for cancerous lesions of the breast include various degrees of mastectomy or lumpectomy, radiation therapy, chemotherapy and combinations of these treatments. However, radiographically visible tissue features, originally observed in a mammogram, may be removed, altered or obscured by the biopsy procedure, and may heal or otherwise become altered following the biopsy. In order for the surgeon or radiation oncologist to direct surgical or radiation treatment to the precise location of the breast lesion several days or weeks after the biopsy procedure was performed, it is desirable that a biopsy site marker be placed in the patient's body to serve as a landmark for subsequent location of the lesion site. A biopsy site marker may be a permanent marker (e.g., a metal marker visible under x-ray examination), or a temporary marker (e.g., a bioresorbable marker detectable with ultrasound). While current radiographic type markers may persist at the biopsy site, an additional mammography generally must be performed at the time of follow up treatment or surgery in order to locate the site of the previous surgery or biopsy. In addition, once the site of the previous procedure is located using mammography, the site must usually be marked with a location wire which has a hook on the end which is advanced into site of the previous procedure. The hook is meant to fix the tip of the location wire with respect to the site of the previous procedure so that the patient can then be removed from the confinement of the mammography apparatus and the follow-up procedure performed. However, as the patient is removed from the mammography apparatus, or otherwise transported the position of the location wire can change or shift in relation to the site of the previous procedure. This, in turn, can result in follow-up treatments being misdirected to an undesired portion of the patient's tissue.
  • [0009]
    As an alternative or adjunct to radiographic imaging, ultrasonic imaging (herein abbreviated as “USI”) or visualization techniques can be used to image the tissue of interest at the site of interest during a surgical or biopsy procedure or follow-up procedure. USI is capable of providing precise location and imaging of suspicious tissue, surrounding tissue and biopsy instruments within the patient's body during a procedure. Such imaging facilitates accurate and controllable removal or sampling of the suspicious tissue so as to minimize trauma to surrounding healthy tissue.
  • [0010]
    For example, during a breast biopsy procedure, the biopsy device is often imaged with USI while the device is being inserted into the patient's breast and activated to remove a sample of suspicious breast tissue. As USI is often used to image tissue during follow-up treatment, it may be desirable to have a marker, similar to the radiographic markers discussed above, which can be placed in a patient's body at the site of a surgical procedure and which are visible using USI. Such a marker enables a follow-up procedure to be performed without the need for traditional radiographic mammography imaging which, as discussed above, can be subject to inaccuracies as a result of shifting of the location wire as well as being tedious and uncomfortable for the patient.
  • [0011]
    Placement of a marker or multiple markers at a location within a patient's body requires delivery devices capable of holding markers within the device until the device is properly situated within a breast or other body location. Accordingly, devices and methods for retaining markers within a marker delivery device while allowing their expulsion from the devices at desired intracorporeal locations are desired.
  • SUMMARY OF THE INVENTION
  • [0012]
    The invention is generally directed to the delivery of one or more markers to an intracorporeal site within a patient's body. A marker delivery device embodying features of the invention include a delivery tube or cannula having an inner lumen leading to a discharge opening and having a releasable plug which is disposed at least in part within the inner lumen and which at least partially occludes the discharge opening in the distal end of the delivery tube.
  • [0013]
    The releasable plug is configured to occlude or block off the discharge opening of the delivery cannula or the inner lumen leading thereto to prevent tissue and fluid from entering the inner lumen through the discharge opening during delivery and to hold in any other markers within the inner lumen proximal to the releasable plug during handling and delivery. In one embodiment having features of the invention, the delivery device has a releasable plug with a remotely detectable marker element incorporated therein. Preferably, the marker element incorporated into the releasable plug is non-magnetic and remotely detectable by magnetic resonance imaging.
  • [0014]
    In yet another embodiment having features of the invention, the delivery device has a releasable plug and has at least one short term, remotely detectable marker mass in the inner lumen or at least one fibrous marker in the inner lumen proximal to the releasable plug. Preferably, at least one short term marker and at least one fibrous marker are disposed within the inner lumen of the delivery cannula.
  • [0015]
    The releasable plug may be secured within the inner lumen by a variety of means, but It is preferred to press fit the plug into the distal portion of the inner lumen so as to occlude the discharge opening. However, the plug may alternatively be mechanically or adhesively secured within the distal portion of the inner lumen. For further plug details see co-pending application Ser. No. 10/174,401, filed on Jun. 17, 2002, entitled Plugged Tip Delivery Tube For Marker Placement which is incorporated herein in its entirety by reference. However, the releasable plug should be configured to be easily pushed out of the discharge opening of the delivery cannula, even if the releasable plug has swollen due to contact with a water based fluid. As described above, the releasable plug preferably has a non-magnetic, MRI detectable element which does not interfere with the subsequent imaging of adjacent tissue. The MRI detectable element is about 0.5 to about 5 mm in maximum dimension, preferably about 1 to about 3 mm. Suitable non-magnetic, MRI detectable materials include titanium, platinum, gold, iridium, tantalum, tungsten, silver, rhodium and the like.
  • [0016]
    The releasable plug is formed of a biocompatible, preferably bioabsorbable material such as oxidized regenerated cellulose, polyethylene glycol, polylactic acid, polyglycolic acid, polycaproic acid, and copolymers, polymer alloys, polymer blends, and combinations thereof. Preferable materials are oxidized regenerated cellulose and polymers of polyethylene glycol with molecular weights of about 5000 to about 120,000 Daltons. The releasable plug should be formed of a water swellable material, so that it swells upon contact with water based fluids (e.g. body fluids) to further occlude or otherwise seal the discharge opening of the delivery cannula and thereby prevent premature contact of body fluids with any markers within the inner lumen proximal to the releasable plug. The plug may also be formed of fibrous materials and be in the form of a fibrous marker described below.
  • [0017]
    The short term markers disposed within the inner lumen of the delivery cannula proximal to the releasable plug should be remotely detectable for at least two weeks, preferably at least up to six weeks, but not longer than about one year, preferably not more than about six months, so as to not interfere with subsequent imaging of the target site. The short term markers are preferably formed of bioabsorbable polymeric materials such as polymers of lactic acid, glycolic acid and caprolactones and copolymers and blends thereof. Other suitable materials include those described in co-pending application Ser. No. 09/717,909, filed Nov. 20, 2000 and co-pending application Ser. No. 10/124,757, filed on Jun. 17, 2002, both of which are incorporated by reference in their entireties. The plug and the short term markers may be formed of the same or similar material. The releasable plug may also be formed of fibrous material and be in the form of the fibrous markers described below.
  • [0018]
    The fibrous marker should be slidably disposed within the inner lumen of the delivery cannula, preferably proximal to at least one short term marker so that upon discharge from the cannula into a target site, the fibrous marker will block the accessing passageway and prevent loss of marker material therethrough. A suitable material for forming the fibrous marker is a felt and/or fiber material formed of oxidized regenerated cellulose which has an in vivo lifetime of a few hours up to about 6 weeks, typically about 3 days to about 4 weeks. However, the fibrous marker may be formed of a bioabsorbable polymer such as polylactic acid or polyglycolic acid, a co-polymer of polylactic acid and polyglycolic acid, polycaprolactone, collagen and mixtures thereof, including mixtures with oxidized regenerated cellulose. Suitable oxidized, regenerated cellulose includes SURGICEL™ from the Ethicon Division of Johnson & Johnson or other suitable oxidized regenerated cellulose which are naturally hemostatic. Alternatively, a hemostatic agent such as collagen, gelatin or polysaccharides may be incorporated into the fibrous material to provide the hemostasis upon contact with blood. A wide variety of other hemostatic agents may be incorporated into the marker. The thrombus formed by the hemostasis is formed very quickly to fill the cavity at the biopsy site and at least temporarily hold the plug and any other markers in position within the cavity. Anesthetic agents to control post procedure pain, chemotherapeutic agents to kill any residual neoplastic tissue and coloring agents (e.g. carbon black and methylene blue) for visual location of the biopsy site, may also be incorporated into the fibrous marker.
  • [0019]
    The fibrous material is formed into an elongated member, e.g. by rolling or folding, and bound in a compressed condition to provide sufficient column strength to facilitate introduction into and discharge from a tubular delivery device. Suitable binding agents for holding the fibrous marker in a compressed condition are water soluble polymers such as polyvinyl alcohol, polyethylene glycol, polyvinyl pyrollidone. One or more radiographically detectable marker elements are provided with at least one of the fibrous markers, preferably centrally located on the elongated marker to ensure that the radiographically detectable element is disposed at a more or less central location within the target site rather than at a site margin.
  • [0020]
    The releasable plug, the short term markers and the fibrous markers may include a variety of therapeutic or diagnostic materials such as hemostatic agents, anesthetic agents, coloring agents, antibiotics, antifungal agents, antiviral agents, chemotherapeutic agents, radioactive agents and the like.
  • [0021]
    The delivery device preferably has a plunger slidably disposed within the inner lumen of the delivery cannula which is movable from an initial position accommodating the releasable plug and any markers proximal to the plug within the tube, to a delivery position to push the plug and any desired number of markers out of the discharge opening in the distal end of the cannula into the target tissue site.
  • [0022]
    Upon being discharged into the intracorporeal target site, the markers at least partially fill the site to enable short term detection by remote imaging and preferably long term detection by remote imaging without interfering with imaging of tissue adjacent to the site. The markers may swell on contact with body fluid, e.g. blood so as to further fill the biopsy cavity. The fibrous marker partially fills the cavity at the target site, positioning the radiopaque marker element within the interior of the target cavity.
  • [0023]
    The marker mass proximal to the releasable plug may be in the form of ultrasound-detectable, bio-resorbable finely-divided particulate material (such as a powder or granulated material), in which many of the particles have internal cavities. Such particulate materials preferably have particle sizes less than about 2000 microns, and typically between about 20 microns and about 2000 microns. For optimum delivery and marker resolution, the particulate should have a particulate size of about 20 microns to about 1500 microns, preferably about 500 microns to about 800 microns. The ultrasound-detectable, bio-resorbable particulate materials may be formed of polymeric materials such as polylactic acid, polyglycolic acid, polycaprolactone, and combinations of these polymers and the particulate may be bound by suitable binding agents such as gelatin, polyethylene glycol, polyvinyl alcohol, glycerin, polysaccharides, other hydrophilic materials, and combinations of these. Suitable gelatins include bovine collagen, porcine collagen, ovine collagen, equine collagen, synthetic collagen, agar, synthetic gelatin, and combinations of these. Further details of the particulate marker material and the delivery thereof can be found in co-pending application Ser. No. 10/124,757, which has been incorporated herein. Polysaccharide particulate or powder may be included with the other particulate materials as a hemostatic agent.
  • [0024]
    The delivery tube of the device may be configured to fit within a guide cannula, such as a Mammotome® or SenoCor 360™ biopsy cannula or a coaxial needle guide.
  • [0025]
    The ultrasound-detectable biopsy site markers of the present invention provide several advantages. A biopsy cavity with marker material having features of the present invention provides a large USI-bright mass, making it much easier, for example, to distinguish the ultrasound signal of the marker from signals arising naturally from within a breast. The marker materials produce bright ultrasound echo signals from one portion of the filled region, which contrasts with the dark ultrasound shadow region immediately behind the bright ultrasound echo region. The strength of the reflected signal, and the contrast with the shadow region, make the marked site readily detectable. Such ready detectability allows, for example, less-experienced physicians to perform the identification by USI and the subsequent surgical resection without the need for an interventional radiologist to identify and mark the biopsy cavity. When a MRI marker element is incorporated into the releasable plug or the short term markers, the target site in which the markers are deployed may be subsequently detected by ultrasound, magnetic resonance and X-ray without interfering with imaging adjacent tissue at a later date.
  • [0026]
    The invention provides the advantages of securely retaining markers within a marker delivery device, improving accuracy and avoiding errors in placement of markers at desired locations within a patient's body, preventing ingress of tissue into the distal tip of the device when it is advanced through tissue, and guiding the device by use of an imaging device including ultrasound, X-ray and magnetic resonance based devices. These and other advantages of the invention will become more apparent from the following description when taken in conjunction with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0027]
    [0027]FIG. 1A is a partly cut-away perspective view of a marker delivery assembly embodying features of the invention.
  • [0028]
    [0028]FIG. 1B is a transverse cross-sectional view of the marker delivery assembly of FIG. 1A taken at line 1B-1B.
  • [0029]
    [0029]FIG. 1C is a transverse cross-sectional view of the marker delivery assembly of FIG. 1A taken at line 1C-1C.
  • [0030]
    [0030]FIG. 2 is an end perspective view of a fibrous marker with a core member suitable for use with a marker delivery system embodying features of the invention.
  • [0031]
    [0031]FIG. 3 is an end perspective view of an alternative fibrous marker without a core member suitable for use with a marker delivery system embodying features of the invention.
  • [0032]
    [0032]FIG. 4A-4F illustrates forming a fibrous marker with a core member as depicted in FIG. 4.
  • [0033]
    [0033]FIG. 5 is a partially cut away, perspective view of a human breast from which a biopsy specimen has been removed, showing a markers being delivered to the biopsy site with the marker delivery assembly shown in FIG. 1A.
  • [0034]
    [0034]FIG. 6 is a partial cut-away view of a human breast shown in FIG. 2 with the markers delivered into the biopsy site and the delivery device removed.
  • [0035]
    [0035]FIG. 7 is a longitudinal cross-sectional view of the distal portion of an alternative marker delivery device embodying features of the invention with a sharp, tissue penetrating distal tip.
  • [0036]
    FIGS. 8 is a longitudinal cross-sectional view of the distal portion of a marker delivery device embodying features of the invention having particulate marker mass proximal to the releasable plug.
  • DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION
  • [0037]
    [0037]FIGS. 1A-1C illustrate a marker delivery device 10 embodying features of the invention which includes a delivery tube or cannula 11 with a bore 12, a distal portion 13, and a proximal portion 14 with a handle 15. A releasable distal plug 16, several (five) short term markers 17, a pair of fibrous markers 18 and 19 and a proximal plug 20 are shown disposed within the bore 12. A plunger 21 is slidably disposed within the tube bore 12, and is provided with a proximal end 22 configured to allow an operator to press the plunger further into the bore 12 and push the releasable plug 16 and one or more of the other markers out of the discharge port or opening 23 in the distal end 24 of delivery tube 11. Cannula handle 15 allows an operator to hold the cannula steady while pressing plunger 21 to discharge the releasable plug 16 and markers 17 and 18.
  • [0038]
    Releasable plug 16 may substantially fill the discharge opening 23, as shown in FIG. 1, or may occupy or block only a portion of the discharge opening 23. The exposed face of plug 16 is preferably provided with an inclined configuration to conform with the inclination of the discharge opening 23.
  • [0039]
    Markers 17, 18 and 19 and proximal plug 20 are preferably configured to slide readily within tube bore 12. Releasable plug 16 is configured to be tight enough, e.g. press fit, in the bore 12 to prevent its inadvertent release which would allow premature discharge of markers 17 and 18 from delivery tube 11 and undesirable contact with body fluid. But the plug 16 must be easily released when the plunger 21 is pressed deeper into the bore 12 of the delivery tube 11. An adhesive or mechanical element(s) may be used to hold the releasable plug 16 in a position within the bore 12 to occlude the discharge opening 23. Suitable adhesives include polyurethane or polyacrylic based adhesives, polyhydroxymethacrylate base adhesives, fibrin glue (e.g., Tisseal™), collagen adhesive, or mixtures thereof. Suitable mechanical means for securing the releasable plug 16 are described in co-pending application Ser. No. 10/174,401 which has been incorporated herein. The distal end 24 of the delivery cannula 11 is provided with a ramp 25 which guides the discharged plug 16 and markers 17, 18 and 19 out of the side port 26 into the target site. The distal tip 27 may be tapered for delivery through a guide tube as shown.
  • [0040]
    The delivery tube 11 may be provided with markings 28 which serve as visual landmarks to aid an operator in accurately placing the distal end 24 of the cannula 11 in a desired location within a patient“s body for discharging the markers. The markings 24 also be radiopaque, ultrasound-reflective, or otherwise configured to be detectable by remote imaging devices and imaging methods.
  • [0041]
    Short term markers 17 are made at least in part with detectable, biocompatible materials. Suitable marker materials include bioresorbable polymeric materials such as poly(esters), poly(hydroxy acids), poly(lactones), poly(amides), poly(ester-amides), poly(amino acids), poly(anhydrides), poly(ortho-esters), poly(carbonates), poly(phosphazines), poly(thioesters), poly(urethanes), poly(ester urethanes), polysaccharides, polylactic acid, polyglycolic acid, polycaproic acid, polybutyric acid, polyvaleric acid, and copolymers, polymer alloys, polymer blends, and combinations thereof. Preferable polymeric materials are polymers of lactic acid, glycolic acid and caprolactones. The short term markers 17 may also be formed at least in part of gelatin. One or more of the short term markers 17 may include a remotely detectable preferably radiopaque element 28.
  • [0042]
    Releasable plug 16 is preferably formed at least in part of oxidized regenerated cellulose or polyethylene glycol, but may be made from the same or similar bioabsorbable materials as marker 17. The polyethylene glycol quickly expands when contacting a water based fluid such as blood, which ensures that the releasable plug seals off the discharge opening to prevent premature contact between body fluid (or other water based fluid) and the markers 17 and 18 within the bore 12. The polyethylene glycol should have a molecular weight of about 5000 to about 20000 Daltons, preferably about 8000 to about 10000 Daltons in the final plug form. The releasable plug 16 preferably has a non-magnetic element 29 incorporated within the body of the releasable plug that is remotely detectable by magnetic resonance imaging (MRI). It may be formed of titanium, platinum, gold, iridium, tantalum, tungsten, silver, rhodium and the like. The MRI detectable element 29 should have a maximum dimension of about 0.5 to about 5 mm, preferably about 1 to about 3 mm to be MRI detectable. Elements with dimensions greater than about 5 mm tend to interfere with the imaging of adjacent tissue.
  • [0043]
    Releasable plug 16 and markers 17 and 18 are configured for a slidable fit within the bore 15 of the delivery tube 11. The exterior of the delivery tube 11 is preferably configured to fit within a guide cannula sized to accept a Mammotome®, Tru-Cut®, or SenoCor® biopsy device. Typically, plug 16 and markers 17 and 18 will have diameters determined by the size of a bore 15 and typically will be about 0.02 inch (0.5 mm) to about 0.5 inch (12 mm), preferably about 0.04 inch (1 mm) to about 0.3 inch (8 mm). Plug 16 may have slightly larger transverse dimensions to provide a tight fit. In addition, plugs 16 and 19 and short term marker 17 will have a length of about 0.04 inch (1 mm) to about 0.8 inch (20 mm), preferably about 0.1 inch (2.5 mm) to about 0.6 inch (15 mm).
  • [0044]
    Releasable plug 16, markers 17, 18 and 19 and plug 20 are configured for a slidable fit within the bore 15 of the delivery tube 11. The exterior of the delivery tube 11 is preferably configured to fit within a guide cannula sized to accept a Mammotome®, Tru-Cut®, or SenoCor® biopsy device. Typically, plug 16 and markers 17 and 18 will have diameters determined by the size of a bore 15 and typically will be about 0.02 inch (0.5 mm) to about 0.5 inch (12 mm), preferably about 0.04 inch (1 mm) to about 0.3 inch (8 mm). Plug 16 may have slightly larger transverse dimensions to provide a tight fit. In addition, plugs 16 and 20 and short term markers 17 will have a length of about 0.04 inch (1 mm) to about 0.8 inch (20 mm), preferably about 0.1 inch (2.5 mm) to about 0.6 inch (15 mm).
  • [0045]
    The fibrous markers 18 and 19 are preferably rolled or folded pieces of fibrous material such as oxidized cellulose or oxidized, regenerated cellulose which has been compressed and impregnated with a binding agent such as polyethylene glycol and freeze dried in the compressed condition. The fibrous material may be rolled up by itself, as shown in FIG. 5, or wrapped about a matt-like core 30 as shown in FIG. 4. The fibrous marker is generally configured to be slidably disposed within the inner lumen of the delivery cannula 11, and before delivery is about 0.5 mm to about 12 mm, preferably about 1 to about 8 mm in diameter and about 5 to about 30 mm, preferably about 10 to about 25 mm in length. Upon contact with a body fluid or other water based fluid, the length of the fibrous marker remains about the same but the wrapped structure unfolds upon swelling to a width of about 5 to about 25 mm, usually about 10 to about 20 mm. With a radiopaque marker element clamped about a center portion of the wrapped fibrous marker, the fibrous marker expands into a generally bow-tie shape when exposed to body fluids. However, even though secured to the fibrous marker, the radiopaque marker element need not restrict the expansion of the fibrous marker.
  • [0046]
    The manufacture and use of fibrous marker 18 with a core 30 is schematically illustrated in FIGS. 4A-4F. A felt pad or mat 31 of oxidized, regenerated cellulose about 0.125 to about 0.375 inch (3.2-9.3 mm), preferably about 0.25 inch (6.4 mm) thick is impregnated with a 10% (Wt.) polyethylene glycol in a 70% isopropyl alcohol solution and then compressed to a mat about 0.03 to about 0.05 inch (0.76-1.3 mm) thick. A reduction in thickness of 80% or more is suitable. The compressed mat 31 is cut up into elongated strips 32 with square or near square transverse cross-sectional shapes which form the core 30. The core 30 is wrapped in a fabric 33 of oxidized regenerated cellulose about 5 to about 10 mm in width and about 20 mm in length, compressed and impregnated with the 10% PEG dispersion and then freeze dried to a diameter of about 0.065 inch (1.65 mm). Elevated temperatures may be employed to dry the material. The fabric 33 should make at least one, preferably two or more complete wraps about the core 30. The wrapped and compressed product may then be cut to a desired length to form the fibrous marker 18. Alternatively, the uncompressed mat 31, the strip 32 and fiber wrap 33 may be provided at the desired length for the fibrous marker 18, wrapped and then compressed. A radiographically detectable marker element 34 may be formed of a radiopaque wire about 0.005 to about 0.01 inch, (0.13-0.25 mm) may then be crimped about or embedded in a central portion (or other desired portion) of the marker 13. The fibrous marker 18 is then ready for deployment. As shown in FIG. 1A, only fibrous marker 18 is provided with marker element 34. Marker 19 may be formed in the same or similar manner but without the radiopaque element 34.
  • [0047]
    Fibrous markers without the core member 30 may be formed by rolling or folding into the desired configuration. The fibrous material, oxidized rayon felt is first impregnated with a 10% PEG dispersion, compressed and then freeze dried. The dried felt material is rolled again compressed in the rolled state, impregnated with a 10-30% PEG solution, and freeze dried in the rolled compressed condition. The rayon felt material can be initially oxidized by treating in a solution of 80% (by vol.) Nitric Acid, 20% (by vol.) Sulfuric Acid and 1% (by weight) Sodium Nitrite. The felt is treated in the oxidizing, acidic solution at room temperature for about 4.5 hours and then rinsed with deionized water.
  • [0048]
    Radiopaque elements 28 and 34 may be made with suitable radiopaque material, including stainless steel, platinum, gold, iridium, titanium, tantalum, tungsten, silver, rhodium, nickel, bismuth, other radiopaque metals, alloys and oxides of these metals, barium salts, iodine salts, iodinated materials, and combinations of these. The radiopaque elements 28 and 34 may also be configured for detection by MRI. Radiopaque materials and markers may be permanent, or may be temporary and not detectable after a period of time subsequent to their placement within a patient. Colorants, such as dyes (e.g., methylene blue and carbon black) and pigments (e.g., barium sulfate), may also be included in markers 17 and 18 and plugs 16 and 19 embodying features of the invention.
  • [0049]
    [0049]FIG. 5 schematically illustrates the use of a marker delivery system 10 to deliver markers to a desired location 35 within a patient's body. The desired location 35 is typically a cavity from which a biopsy sample has been, or is to be, taken, or a lesion that has been or will be removed or otherwise treated. In FIG. 4, the marker delivery system 10 is shown inserted into a breast 40 through a guide cannula 41 until the distal end 24 is disposed at the delivery site, cavity 35 where a tissue specimen has been removed. While an operator holds the system 10 by the handle 15 of the delivery tube 11, the plunger 20 is pressed further into the bore 12 of delivery cannula 11 to discharge the releasable plug 16 and markers 17 and 18 into the cavity 35. FIG. 6 schematically illustrates the plug 16 and markers 17, 18 and 19 within the cavity 35 after deployment. When the markers contact body fluid within the cavity 35, they tend to swell and thereby further fill the cavity. The fibrous markers 18 and 19 generally block the accessing track 36 to the cavity 35 so that none of the smaller markers 17 will be lost through the track 36. Marks 37 are provided on the proximal end of cannula 11 to provide end location information to the operator.
  • [0050]
    [0050]FIG. 7 illustrates the distal portion 50 of cannula 51 of an alternative delivery system that is essentially the same as that shown in FIGS. 1A-1C except that the distal tip 52 of cannula 51 is configured in a needle-like shape. The delivery system cannula 51 may be used in conjunction with a guide cannula (not shown) or the cannula 51 can be inserted directly through tissue to reach the target site without the need for a guide cannula. The releasable plug 53 is secured in the discharge opening 54 as in the previously discussed embodiment. The exposed face 55 of the plug 53 is preferably flush with the discharge opening 54 of the distal tip 52.
  • [0051]
    Insertion of marker delivery devices embodying features of the invention may be performed with or without the aid of an imaging device, such as an ultrasound imaging device, an X-ray imaging device, a MRI device, or other imaging device. Alternatively, or additionally, insertion may be visually guided, or may be guided by palpation or by other means.
  • [0052]
    The size and composition of the short term markers 17 are selected so as to remain in place within the patient and be detectable by ultrasound for at least 2 weeks, preferably at least 6 weeks to have practical clinical value. However, the short term markers should not be detectable by ultrasound after about one year, preferably not after about six months, so as to avoid interfering with subsequent site examination. For most clinical purposes, a suitable in-situ lifespan when the short term marker is ultrasonically detectable is about six to about twenty weeks. The radiopaque and MRI detectable marker elements generally will have much longer lifespans.
  • [0053]
    [0053]FIG. 8 illustrates the distal shaft section 60 of an alternative delivery cannula 61 which has a fibrous releasable plug 62 in the inner lumen 63 of the distal shaft section which at least partially occludes the discharge opening 64 in the distal end of the shaft. The fibrous releasable plug 62 may be formed as shown in FIGS. 2, 3 and 4A-F.
  • [0054]
    The inner lumen proximal to the fibrous releasable plug 62 is filled with a particulate marker material 65. The corresponding parts of the system are the same as that shown in FIGS. 1A-1C. Plunger 66 is slidably disposed within the inner lumen 63 to eject the powdered mass 65. The particulate marker material 65 may be discharged dry or mixed with a suitable fluid and discharged as a slurry.
  • [0055]
    The particulate may be formed of a biocompatible and bio-resorbable polymeric material such as polylactic acid, polyglycolic acid, polycaprolactones, poly(esters), poly(hydroxy acids), poly(lactones), poly(amides), poly(ester-amides), poly(amino acids), poly(anhydrides), poly(ortho-esters), poly(carbonates), poly(phosphazines), poly(thioesters), poly(urethanes), poly(ester urethanes), polysaccharides, polybutyric acid, polyvaleric acid, and copolymers, polymer alloys, polymer mixtures, and combinations thereof. Of those, polylactic acid, polyglycolic acid, and polycaproic acid are preferred. The polymeric material in particulate form should have cavities or entrap bubbles which facilitate remote detection.
  • [0056]
    Suitable particulate materials have particle sizes typically about 20 microns to about 2000 microns, preferably about 20 microns to about 800 microns and more preferably about 300 microns to about 500 microns. The particulate should have cavities for USI with maximum dimensions of about 10 microns to about 500 microns, preferably about 20 microns to about 200 microns. The polymeric particulate materials suitable for use in making ultrasound-detectable biopsy marker materials typically have a bulk density of about 0.8 g/ml to about 1.5 g/ml, preferably about 0.8 g/ml to about 1 g/ml. The particulate may also contain or be mixed with binding agents such as polyethylene glycol, polyvinyl alcohol and the like. Polysaccharide particulate or powder may be incorporated into the particulate mass in amounts up to about 50% (by weight) of the total particulate mass for purposes of hemostasis.
  • [0057]
    While particular forms of the invention have been illustrated and described herein in the context of a breast biopsy site, it will be apparent that the device and methods having features of the invention may find use in a variety of locations and in a variety of applications, in addition to the human breast. Moreover, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated. It is therefore intended that this invention to be defined by the scope of the appended claims as broadly as the prior art will permit, and in view of the specification if need be. Moreover, those skilled in the art will recognize that features shown in one embodiment may be utilized in other embodiments. Terms such as “element”, “member”, “device”, “section”, “portion”, “step”, “means” and words of similar import when used in the following claims shall not be construed as invoking the provisions of 35 U.S.C. §112(6) unless the following claims expressly use the terms “means” followed by a particular function without specific structure or “step” followed by a particular function without specific action. All patents and patent applications referred to above are hereby incorporated by reference in their entirety.

Claims (106)

What is claimed is:
1. A marker delivery device for an intracorporeal tissue site, comprising:
a) an elongated delivery cannula which has a distal end, an inner lumen and a discharge opening in the distal end in communication with the inner lumen;
b) at least one remotely detectable marker mass which is disposed within the inner lumen of the delivery cannula; and
c) a releasable plug which has a remotely detectable element incorporated therein and which is disposed at least in part within a distal portion of the inner lumen distal to the remotely detectable marker mass so as to occlude the discharge opening in the distal end.
2. The marker delivery device of claim 1 wherein the releasable plug is formed at least in part of oxidized cellulose.
3. The marker delivery device of claim 1 wherein the releasable plug is formed at least in part of a material which expands in the presence of body fluids.
4. The marker delivery device of claim 1 wherein the releasable plug is formed at least in part of polyethylene glycol.
5. The marker delivery device of claim 4 wherein the polyethylene glycol of which the releasable plug is at least partially formed has a molecular weight of about 5000 to about 120,000 Daltons.
6. The marker delivery device of claim 4 wherein the polyethylene glycol of which the releasable plug is at least partially formed has a molecular weight of about 5000 to about 20,000 Daltons.
7. The marker delivery device of claim 4 wherein the polyethylene glycol of which the releasable plug is at least partially formed has a molecular weight of about 8000 to about 10,000 Daltons.
8. The marker delivery device of claim 1 wherein the releasable plug has a non-magnetic marker element which is remotely detectable by magnetic resonance.
9. The marker delivery device of claim 1 wherein the marker element is formed of a material selected from the group consisting of titanium, platinum, gold, iridium, tantalum, tungsten, silver, rhodium.
10. The marker delivery device of claim 1 wherein the at least one remotely detectable marker body is formed at least in part of fibrous material.
11. The marker delivery device of claim 10 wherein the at least one fibrous marker body has a radiographic detectable element
12. The marker delivery device of claim 10 wherein the at least one fibrous marker body is formed at least in part of a bioabsorbable fibrous material.
13. The marker delivery device of claim 10 wherein the at least one fibrous marker body is formed of oxidized cellulose.
14. The marker delivery device of claim 10 wherein at least one fibrous marker body is formed of oxidized regenerated cellulose.
15. The marker delivery device of claim 11 wherein the radiographically detectable element surrounds an exterior portion of the fibrous marker body.
16. The marker delivery device of claim 1 wherein at least one remotely detectable marker mass is formed of polymeric material selected from the group consisting of polylactic acids, polyglycolic acids, copolymers and blends thereof and is disposed in the inner lumen proximal to the releasable plug.
17. The marker delivery device of claim 15 wherein at least one remotely detectable fibrous marker body formed at least in part of bioabsorbable fibrous material selected from the group consisting of oxidized cellulose and oxidized regenerated cellulose is disposed proximal to the remotely detectable marker bodies formed of polymeric material.
18. The marker delivery device of claim 1 wherein the releasable plug tip is formed at least in part of fibrous material.
19. The marker delivery device of claim 18 wherein the fibrous releasable plug tip has a radiographic detectable element.
20. The marker delivery device of claim 18 wherein the releasable plug tip is formed at least in part of a bioabsorbable fibrous material.
21. The marker delivery device of claim 18 wherein the fibrous releasable plug tip is formed of oxidized cellulose.
22. The marker delivery device of claim 18 wherein the fibrous releasable plug tip is formed of oxidized regenerated cellulose.
23. The marker delivery device of claim 19 wherein the radiographically detectable element surrounds an exterior portion of the fibrous releasable plug tip.
24. The marker delivery device of claim 18 wherein at least one remotely detectable marker mass is formed of polymeric material selected from the group consisting of polylactic acids, polyglycolic acids, copolymers and blends thereof and is disposed in the inner lumen proximal to the fibrous releasable plug.
25. The marker delivery device of claim 21 wherein the fibrous releasable plug tip is formed at least in part of bioabsorbable fibrous material selected from the group consisting of oxidized cellulose and oxidized regenerated cellulose is disposed proximal to the remotely detectable marker bodies formed of polymeric material.
26. The marker delivery device of claim 1 including a plunger which is slidably disposed within the inner lumen of the cannula and which has a distal end proximal to marker bodies in the inner lumen.
27. A marker delivery device for an intracorporeal tissue site, comprising:
a) an elongated delivery cannula which has a distal end, a discharge opening in the distal end and an inner lumen extending to and in communication with the discharge opening; and
b) a releasable plug which has an MRI detectable marker element incorporated therein and which is disposed at least in part within a distal portion of the inner lumen so as to occlude the discharge opening in the distal end.
28. The marker delivery device of claim 27 wherein the releasable plug is formed at least in part of a material selected from the group consisting of oxidized cellulose or oxidized regenerated cellulose.
29. The marker delivery device of claim 27 wherein the releasable plug is formed at least in part of a material which expands in the presence of body fluids.
30. The marker delivery device of claim 29 wherein the releasable plug is formed at least in part of polyethylene glycol.
31. The marker delivery device of claim 27 wherein at least one remotely detectable marker body is slidably disposed within the inner lumen of the delivery cannula proximal to the releasable plug.
32. The marker delivery device of claim 31 wherein the at least one remotely detectable marker body disposed proximal to the releasable plug is formed at least in part of fibrous material.
33. The marker delivery device of claim 32 wherein the fibrous marker body is expandable upon contact with body fluid or other water based fluid.
34. The marker delivery device of claim 32 wherein the fibrous material is bioabsorbable.
35. The marker delivery device of claim 34 wherein the fibrous material is oxidized cellulose.
36. The marker delivery device of claim 34 wherein the fibrous material is oxidized regenerated cellulose.
37. The marker delivery device of claim 32 wherein the at least one marker body formed of fibrous material has a radiographic imageable element.
38. The marker delivery device of claim 37 wherein the radiographically detectable element surrounds a portion of the fibrous marker body.
39. The marker delivery device of claim 27 wherein a plunger is slidably disposed within the inner lumen of the cannula with a pusher end proximal to the marker bodies in the inner lumen.
40. The marker delivery device of claim 27 wherein the MRI detectable marker element is about 0.5 to about 5 mm in maximum dimension.
41. The marker delivery device of claim 27 wherein the MRI detectable marker element is about 1 to about 3 mm in maximum dimension.
42. A marker delivery device system for an intracorporeal site within a patient, comprising:
a. an elongated delivery cannula which has a distal end, a discharge opening in the distal end and an inner lumen extending to and in communication with the discharge opening;
b. a releasable plug disposed within the inner lumen so as to at least partially occlude the discharge opening; and
c. at least one remotely detectable, short term marker disposed within the inner bore proximal to the releasable plug; and
d. at least one fibrous marker disposed within the inner lumen proximal to the at least one short term marker.
43. The marker delivery device of claim 42 wherein the releasable plug is formed at least in part of a material which expands in the presence of body fluids.
44. The marker delivery device of claim 42 wherein the releasable plug is formed at least in part of polyethylene glycol.
45. The marker delivery device of claim 42 wherein the releasable plug is covered with polyethylene glycol.
46. The marker delivery device of claim 42 wherein at least one remotely detectable marker body is slidably disposed within the inner lumen of the delivery cannula distal to the releasable plug.
47. The marker delivery device of claim 42 wherein the at least one remotely detectable marker body disposed distal to the releasable plug is formed at least in part of fibrous material.
48. The marker delivery device of claim 47 wherein the fibrous material is bioabsorbable.
49. The marker delivery device of claim 46 wherein the fibrous material is oxidized cellulose.
50. The marker delivery device of claim 46 wherein the fibrous material is oxidized regenerated cellulose.
51. The marker delivery device of claim 46 wherein the at least one marker body formed of fibrous material has a radiographic imageable element
52. The marker delivery device of claim 51 wherein the radiographically detectable element surrounds a portion of the fibrous marker body.
53. The marker delivery device of claim 42 wherein a plunger is slidably disposed within the inner lumen of the cannula with a pusher end proximal to the marker bodies in the inner lumen.
54. The marker delivery device of claim 42 wherein the releasable plug has a non-magnetic, MRI detectable marker element incorporated therein.
55. The marker delivery device of claim 54 wherein the non-magnetic, MRI detectable marker element is formed of a material selected from the group consisting of titanium, platinum, gold, iridium, tantalum, tungsten, silver and rhodium.
56. The marker delivery device of claim 54 wherein the non-magnetic, MRI detectable marker element is about 0.5 to about 5 mm in maximum dimension.
57. The marker delivery device of claim 54 wherein the non-magnetic, MRI detectable marker element is about 1 to about 3 mm in maximum dimension.
58. A marker delivery device for an intracorporeal tissue site, comprising:
a) an elongated delivery cannula which has a distal end, an inner lumen and a discharge opening in the distal end in communication with the inner lumen;
b) at least one remotely detectable marker mass which is formed at least in part of particulate and which is disposed within the inner lumen of the delivery cannula; and
c) a releasable plug which has a remotely detectable element incorporated therein and which is disposed at least in part within a distal portion of the inner lumen distal to the remotely detectable marker mass so as to occlude the discharge opening in the distal end.
59. The marker delivery device of claim 58 wherein the marker mass is remotely detectable by ultrasound.
60. The marker delivery device of claim 58 wherein the particulate of the marker mass is formed of bio-resorbable material.
61. The marker delivery device of claim 58 wherein the particulate has a particle size of about 20 to about 2000 microns.
62. The marker delivery device of claim 58 wherein the particulate has a particle size of about 100 microns to about 1500 microns.
63. The marker delivery device of claim 58 wherein the particulate has a particle size of about 500 microns to about 900 microns.
64. The marker delivery device of claim 58 wherein the particulate has bubble cavities.
65. The marker delivery device of claim 64 wherein the bubble cavities of the particulate is about 10 microns to about 500 microns in maximum dimension.
66. The marker delivery device of claim 64 wherein the bubble cavities of the particulate are about 50 microns to about 200 microns.
67. The marker delivery device of claim 60 wherein the particulate is formed at least in part of bio-resorbable polymeric material selected from the group consisting of poly(esters), poly(hydroxy acids), poly(lactones), poly(amides), poly(ester-amides), poly(amino acids), poly(anhydrides), poly(ortho-esters), poly(carbonates), poly(phosphazines), poly(thioesters), poly(urethanes), poly(ester urethanes), polysaccharides, polylactic acids, polyglycolic acids, polycaproic acids, polybutyric acids, polyvaleric acids, and copolymers, polymer alloys, polymer mixtures, and combinations thereof.
68. The marker delivery device of claim 60 wherein the particulate is formed at least in part of bio-resorbable polymeric material selected from the group consisting of polylactic acids, polyglycolic acids, polycaproic acids, and copolymers, polymer alloys, polymer mixtures, and combinations thereof.
69. The marker delivery device of claim 52 wherein the bio-resorbable material comprises about 65% by weight polylactic acid and about 35% by weight polyglycolic acid.
70. The ultrasound-detectable biopsy marker mass of claim 58, wherein said bio-resorbable polymeric material comprises a polymeric material having an average molecular weight of less than about 60 kD selected from the group consisting of polylactic acid and polycaproic acid polymers, copolymers, polymer alloys, polymer mixtures, and combinations thereof.
71. The marker delivery device of claim 60 wherein the particulate has a bulk density of about 0.8 g/ml to about 1.1 g/ml.
72. The marker delivery device of claim 60 wherein the particulate is held together by a binding agent.
73. The marker delivery device of claim 72 wherein the binding agent is selected from the group consisting of gelatin, polyethylene glycol, polyvinyl alcohol, glycerin, acrylic hydrogels, organic hydrogels, polysaccharides and combinations thereof.
74. The marker delivery device of claim 60 wherein the marker mass comprises gelatin and bio-resorbable polymeric particulate material having bubble cavities.
75. The marker delivery device of claim 74 wherein the gelatin binding agent is selected from the group consisting of bovine collagen, porcine collagen, ovine collagen, equine collagen, synthetic collagen, agar, synthetic gelatin, and combinations thereof.
76. An intracorporeal marker comprising an expandable bioabsorbable fibrous body with a radiopaque marker element secured to the fibrous body.
77. The intracorporeal marker of claim 76 wherein the radiopaque marker element is incorporated into the fibrous body.
78. The intracorporeal marker of claim 76 wherein the radiopaque marker is disposed about the fibrous body.
79. The intracorporeal marker of claim 76 wherein the radiopaque marker is incorporated into the fibrous body.
80. The intracorporeal marker of claim 76 wherein the fibrous body is formed at least in part of a bioabsorbable material selected from the group consisting of oxidized cellulose, oxidized regenerated cellulose, polylactic acid, a copolymer of polylactic acid and glycolic acid, and polycaprolactone.
81. The intracorporeal marker of claim 80 wherein the cellulose is oxidized, regenerated cellulose.
82. The intracorporeal marker of claim 76 wherein the fibrous body is formed of material which swells in the presence of body fluids or other water based fluids.
83. The intracorporeal marker of claim 76 wherein the fibrous body is formed at least in part of woven fabric.
84. The intracorporeal marker of claim 76 wherein the fibrous body is formed at least in part of felt fabric.
85. The intracorporeal marker of claim 76 wherein the fibrous body is compressed.
86. The intracorporeal marker of claim 85 wherein the compressed fibrous body has incorporated therein a binding agent to hold the fibrous body in the compressed condition.
87. The intracorporeal marker of claim 86 wherein the binding agent is selected from the group consisting of water soluble polymers selected from the group consisting of polyvinyl alcohol, polyethylene glycol and polyvinyl pyrollidone.
88. The intracorporeal marker of claim 76 wherein the fibrous body includes at least one bioactive component selected from the group consisting of therapeutic and diagnostic agents incorporated therein.
89. The intracorporeal expandable marker of claim 88 wherein the incorporated therapeutic or diagnostic agent is selected from the group consisting of a hemostatic agent, an anesthetic agent, a coloring agent, an antibiotic agent, an antifungal agent, an antiviral agent, a chemotherapeutic agent and a radioactive agent.
90. The intracorporeal expandable marker of claim 78 wherein the fibrous body contains a bioabsorbable material selected from the group consisting of polylactic acid, a co-polymer of polylactic acid and glycolic acid, polycaprolactone, collagen and mixtures thereof, including mixtures with the oxidized cellulose.
91. The intracorporeal expandable marker of claim 78 wherein the fibrous body includes a binding agent.
92. The intracorporeal expandable marker of claim 76 wherein the radiographically detectable marker element is disposed at a central portion of the fibrous body.
93. The intracorporeal expandable marker of claim 76 wherein a constricting member holds a portion of the fibrous body to prevent its expansion.
94. The intracorporeal expandable marker of claim 93 wherein the constricting member holds a central portion of the fibrous body to prevent its expansion.
95. The intracorporeal expandable marker of claim 76 wherein the radiographically detectable marker element is a constricting member which holds a portion of the fibrous body to prevent its expansion.
96. The intracorporeal expandable marker of claim 95 wherein the radiographically detectable constricting member holds a central portion of the fibrous body to prevent its expansion.
97. The intracorporeal expandable marker of claim 96 wherein the constricted fibrous body is configured to expand into a bow-tie shape when exposed to body fluid or other water based fluid.
98. The intracorporeal expandable marker of claim 76 wherein the fibrous body has a core formed of bioabsorbable felt surrounded by a bioabsorbable fabric jacket.
99. The intracorporeal expandable marker of claim 95 wherein the radiographically detectable marker element is a radiopaque wire element clamped about a central exterior portion of the fibrous body.
100. The expandable intracorporeal marker of claim 95 wherein the fibrous mass has been compressed at least 25%.
101. An intracorporeal marker comprising a compressed expandable bioabsorbable fibrous body which has been compressed and bound in the compressed condition.
102. The intracorporeal marker of claim 101 wherein the fibrous body is bound by a binding agent selected from the group consisting of water soluble polymers selected from the group consisting of polyvinyl alcohol, polyethylene glycol and polyvinyl pyrollidone.
103. The intracorporeal marker of claim 101 wherein the fibrous body is about 0.5 mm to about 12 mm in diameter.
104. The intracorporeal marker of claim 101 wherein the fibrous body is, about 1 to about 8 mm in diameter.
105. The intracorporeal marker of claim 101 wherein the fibrous body is about 5 to about 30 mm in length.
106. The intracorporeal marker of claim 101 wherein the fibrous body is about 10 to about 25 mm in length.
US10753694 2003-05-23 2004-01-07 Marker delivery device with releasable plug Abandoned US20040236213A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10444770 US7983734B2 (en) 2003-05-23 2003-05-23 Fibrous marker and intracorporeal delivery thereof
US10753694 US20040236213A1 (en) 2003-05-23 2004-01-07 Marker delivery device with releasable plug

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US10753694 US20040236213A1 (en) 2003-05-23 2004-01-07 Marker delivery device with releasable plug
US12214398 US7970454B2 (en) 2003-05-23 2008-06-18 Marker delivery device with releasable plug
US13037971 US8361082B2 (en) 1999-02-02 2011-03-01 Marker delivery device with releasable plug
US13082463 US8498693B2 (en) 1999-02-02 2011-04-08 Intracorporeal marker and marker delivery device
US13301297 US20120078092A1 (en) 1999-02-02 2011-11-21 Remotely imageable marker system and polysaccharide marker for use in same
US13301024 US9149341B2 (en) 1999-02-02 2011-11-21 Deployment of polysaccharide markers for treating a site within a patient
US13750341 US9044162B2 (en) 1999-02-02 2013-01-25 Marker delivery device with releasable plug
US13922860 US20130281847A1 (en) 1999-02-02 2013-06-20 Intracorporeal marker and marker delivery device
US14608939 US9861294B2 (en) 1999-02-02 2015-01-29 Marker delivery device with releasable plug
US14868663 US9820824B2 (en) 1999-02-02 2015-09-29 Deployment of polysaccharide markers for treating a site within a patent

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
US10444770 Continuation-In-Part US7983734B2 (en) 2003-05-23 2003-05-23 Fibrous marker and intracorporeal delivery thereof
US13082463 Continuation-In-Part US8498693B2 (en) 1999-02-02 2011-04-08 Intracorporeal marker and marker delivery device
US13301024 Continuation-In-Part US9149341B2 (en) 1999-02-02 2011-11-21 Deployment of polysaccharide markers for treating a site within a patient

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12214398 Division US7970454B2 (en) 2003-05-23 2008-06-18 Marker delivery device with releasable plug
US13037971 Continuation-In-Part US8361082B2 (en) 1999-02-02 2011-03-01 Marker delivery device with releasable plug

Publications (1)

Publication Number Publication Date
US20040236213A1 true true US20040236213A1 (en) 2004-11-25

Family

ID=33450746

Family Applications (6)

Application Number Title Priority Date Filing Date
US10444770 Active 2027-02-13 US7983734B2 (en) 2003-05-23 2003-05-23 Fibrous marker and intracorporeal delivery thereof
US10753694 Abandoned US20040236213A1 (en) 2003-05-23 2004-01-07 Marker delivery device with releasable plug
US12214398 Active 2023-11-20 US7970454B2 (en) 2003-05-23 2008-06-18 Marker delivery device with releasable plug
US13155628 Active US8626269B2 (en) 2003-05-23 2011-06-08 Fibrous marker and intracorporeal delivery thereof
US13946175 Active US8880154B2 (en) 2003-05-23 2013-07-19 Fibrous marker and intracorporeal delivery thereof
US14519531 Active 2024-07-05 US9801688B2 (en) 2003-05-23 2014-10-21 Fibrous marker and intracorporeal delivery thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10444770 Active 2027-02-13 US7983734B2 (en) 2003-05-23 2003-05-23 Fibrous marker and intracorporeal delivery thereof

Family Applications After (4)

Application Number Title Priority Date Filing Date
US12214398 Active 2023-11-20 US7970454B2 (en) 2003-05-23 2008-06-18 Marker delivery device with releasable plug
US13155628 Active US8626269B2 (en) 2003-05-23 2011-06-08 Fibrous marker and intracorporeal delivery thereof
US13946175 Active US8880154B2 (en) 2003-05-23 2013-07-19 Fibrous marker and intracorporeal delivery thereof
US14519531 Active 2024-07-05 US9801688B2 (en) 2003-05-23 2014-10-21 Fibrous marker and intracorporeal delivery thereof

Country Status (6)

Country Link
US (6) US7983734B2 (en)
JP (1) JP2006528907A (en)
CA (1) CA2526592C (en)
EP (2) EP2550927A1 (en)
ES (1) ES2561390T3 (en)
WO (1) WO2004105626A3 (en)

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030233101A1 (en) * 2002-06-17 2003-12-18 Senorx, Inc. Plugged tip delivery tube for marker placement
US20040236212A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US20050119562A1 (en) * 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US20050277871A1 (en) * 2004-06-11 2005-12-15 Selis James E Biopsy devices and methods
US20060036165A1 (en) * 1999-02-02 2006-02-16 Senorx, Inc. Tissue site markers for in vivo imaging
US20060084865A1 (en) * 1999-02-02 2006-04-20 Burbank Fred H Imageable biopsy site marker
US20070055090A1 (en) * 2004-08-12 2007-03-08 Navotek Medical Ltd. Medical Treatment System and Method
US20070110665A1 (en) * 2005-11-17 2007-05-17 Bolan Patrick J Tissue marker for multimodality radiographic imaging
US20080234532A1 (en) * 2005-10-22 2008-09-25 Invibio Limited Fiducial marker
US20080262473A1 (en) * 2004-10-19 2008-10-23 Navotek Medical Ltd. Locating a Catheter Tip Using a Tracked Guide
US20080287729A1 (en) * 2007-05-16 2008-11-20 Anthony Biscotti Interstitial marker and method for creation thereof
US20090127459A1 (en) * 2004-08-12 2009-05-21 Navotek Medical Ltd. Localization of a Radioactive Source
US20090131734A1 (en) * 2006-02-16 2009-05-21 Navotek Medical Ltd. Implantable medical marker and methods of preparation thereof
US20090171199A1 (en) * 2006-02-03 2009-07-02 Anders Widmark Method and instrument as well as use of instrument for permanent application of reference marker for precision aiming of treatment beam
US20090171198A1 (en) * 2006-08-04 2009-07-02 Jones Michael L Powdered marker
US20090216150A1 (en) * 2008-02-25 2009-08-27 Lee Reichel Method and Apparatus For Inserting Biopsy Site Marker In Marker Body
US20090216181A1 (en) * 2008-02-25 2009-08-27 Speeg Trevor W V Biopsy Site Marker Deployment Instrument
US20100042041A1 (en) * 2008-08-18 2010-02-18 Navotek Medical Ltd. Implantation device for soft tissue markers and other implants
US20100106168A1 (en) * 2002-08-01 2010-04-29 Selis James E Biopsy devices and methods
US7792569B2 (en) 1999-02-02 2010-09-07 Senorx, Inc. Cavity-filling biopsy site markers
US20100280367A1 (en) * 2009-04-30 2010-11-04 Ducharme Richard W System and method for fiducial deployment
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20110071424A1 (en) * 2009-09-22 2011-03-24 Nock Andrew P Biopsy marker delivery device
US20110184449A1 (en) * 2006-08-04 2011-07-28 Senorx, Inc. Marker delivery device with obturator
US8164064B2 (en) 2004-08-12 2012-04-24 Navotek Medical Ltd. Localization of a radioactive source within a body of a subject
US20120116215A1 (en) * 1999-02-02 2012-05-10 Jones Michael L Deployment of polysaccharide markers for treating a site within a patient
US8311610B2 (en) 2008-01-31 2012-11-13 C. R. Bard, Inc. Biopsy tissue marker
US8401622B2 (en) 2006-12-18 2013-03-19 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
US8437834B2 (en) 2006-10-23 2013-05-07 C. R. Bard, Inc. Breast marker
US20130123829A1 (en) * 2006-11-24 2013-05-16 Senorx, Inc. Mri detectable obturator
US8486028B2 (en) 2005-10-07 2013-07-16 Bard Peripheral Vascular, Inc. Tissue marking apparatus having drug-eluting tissue marker
US8579931B2 (en) 1999-06-17 2013-11-12 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
US8634899B2 (en) 2003-11-17 2014-01-21 Bard Peripheral Vascular, Inc. Multi mode imaging marker
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US8670818B2 (en) 2008-12-30 2014-03-11 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US8718745B2 (en) 2000-11-20 2014-05-06 Senorx, Inc. Tissue site markers for in vivo imaging
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
US9044162B2 (en) 1999-02-02 2015-06-02 Senorx, Inc. Marker delivery device with releasable plug
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US9427186B2 (en) 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
US9522264B2 (en) 2013-02-26 2016-12-20 Cook Medical Technologies Llc Ratchet-slide handle and system for fiducial deployment
US9579077B2 (en) 2006-12-12 2017-02-28 C.R. Bard, Inc. Multiple imaging mode tissue marker
US9622822B2 (en) 2007-05-01 2017-04-18 Suros Surgical Systems, Inc. Securement for a surgical site marker and deployment device for same
US9770262B2 (en) 2014-06-09 2017-09-26 Cook Medical Technologies Llc Screw-driven handles and systems for fiducial deployment
US9795455B2 (en) 2014-08-22 2017-10-24 Breast-Med, Inc. Tissue marker for multimodality radiographic imaging
US9808539B2 (en) 2013-03-11 2017-11-07 Endomagnetics Ltd. Hypoosmotic solutions for lymph node detection
US9848956B2 (en) 2002-11-18 2017-12-26 Bard Peripheral Vascular, Inc. Self-contained, self-piercing, side-expelling marking apparatus

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
GB0120645D0 (en) 2001-08-24 2001-10-17 Smiths Group Plc Medico-surgical devices
CA2479339C (en) 2002-03-19 2013-03-12 Bard Dublin Itc Limited Vacuum biopsy device
EP1524940B1 (en) 2002-03-19 2011-08-24 Bard Dublin ITC Limited Biopsy device and biopsy needle module that can be inserted into the biopsy device
DE10314240A1 (en) 2003-03-29 2004-10-07 Bard Dublin Itc Ltd., Crawley Pressure generating unit
US7783336B2 (en) * 2003-06-06 2010-08-24 Ethicon Endo-Surgery, Inc. Subcutaneous biopsy cavity marker device
US7001341B2 (en) * 2003-08-13 2006-02-21 Scimed Life Systems, Inc. Marking biopsy sites
EP1768571B1 (en) 2004-07-09 2012-03-21 Bard Peripheral Vascular, Inc. Firing system for biopsy device
US8280486B2 (en) * 2004-10-13 2012-10-02 Suros Surgical Systems, Inc. Site marker visable under multiple modalities
US8419656B2 (en) 2004-11-22 2013-04-16 Bard Peripheral Vascular, Inc. Post decompression marker introducer system
US7517321B2 (en) 2005-01-31 2009-04-14 C. R. Bard, Inc. Quick cycle biopsy system
CA2616714C (en) 2005-08-10 2017-01-24 Jon Taylor Single-insertion, multiple sample biopsy device with integrated markers
EP2196154B1 (en) 2005-08-10 2012-01-18 C.R.Bard, Inc. Transport system for single-insertion, multiple sample biopsy devices
EP1921998A4 (en) 2005-08-10 2017-07-19 Bard Inc C R Single-insertion, multiple sampling biopsy device with linear drive
US20080294039A1 (en) * 2006-08-04 2008-11-27 Senorx, Inc. Assembly with hemostatic and radiographically detectable pellets
US20080039819A1 (en) * 2006-08-04 2008-02-14 Senorx, Inc. Marker formed of starch or other suitable polysaccharide
WO2008024684A3 (en) 2006-08-21 2008-07-03 Bard Inc C R Self-contained handheld biopsy needle
DE602007011659D1 (en) 2006-10-06 2011-02-10 Bard Peripheral Vascular Inc Tissue handling system with reduced exposure of the operator
GB0722406D0 (en) * 2007-11-15 2007-12-27 Smiths Group Plc Medico-surgical assemblies and methods
WO2009069534A3 (en) * 2007-11-30 2009-09-24 Tonen Chemical Corporation Microporous polymeric membrane, battery separator, and battery
US8241225B2 (en) 2007-12-20 2012-08-14 C. R. Bard, Inc. Biopsy device
US7854706B2 (en) 2007-12-27 2010-12-21 Devicor Medical Products, Inc. Clutch and valving system for tetherless biopsy device
US20090209853A1 (en) * 2008-02-19 2009-08-20 Parihar Shailendra K Biopsy site marker applier
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US8702677B2 (en) * 2008-10-31 2014-04-22 Warsaw Orthopedic, Inc. Device and method for directional delivery of a drug depot
US20100204570A1 (en) * 2009-02-06 2010-08-12 Paul Lubock Anchor markers
EP2408378A4 (en) 2009-03-16 2013-10-09 Bard Inc C R Biopsy device having rotational cutting
WO2010120294A1 (en) 2009-04-15 2010-10-21 C.R. Bard, Inc. Biopsy apparatus having integrated fluid management
US8206316B2 (en) 2009-06-12 2012-06-26 Devicor Medical Products, Inc. Tetherless biopsy device with reusable portion
US9173641B2 (en) 2009-08-12 2015-11-03 C. R. Bard, Inc. Biopsy apparatus having integrated thumbwheel mechanism for manual rotation of biopsy cannula
US8485989B2 (en) 2009-09-01 2013-07-16 Bard Peripheral Vascular, Inc. Biopsy apparatus having a tissue sample retrieval mechanism
US20110071391A1 (en) * 2009-09-24 2011-03-24 Speeg Trevor W V Biopsy marker delivery device with positioning component
USD640977S1 (en) 2009-09-25 2011-07-05 C. R. Bard, Inc. Charging station for a battery operated biopsy device
US8597206B2 (en) 2009-10-12 2013-12-03 Bard Peripheral Vascular, Inc. Biopsy probe assembly having a mechanism to prevent misalignment of components prior to installation
US8430824B2 (en) 2009-10-29 2013-04-30 Bard Peripheral Vascular, Inc. Biopsy driver assembly having a control circuit for conserving battery power
EP2508219A1 (en) 2011-04-05 2012-10-10 Tyco Healthcare Group LP Buffering agent delivery system for anesthetic syringe
ES2549215T3 (en) * 2011-05-06 2015-10-26 W.L. Gore & Associates, Inc. echogenic sleeve
WO2012154988A3 (en) * 2011-05-11 2013-03-07 The Regents Of The University Of California Fiduciary markers and methods of placement
EP2945543A4 (en) * 2013-01-18 2016-09-21 Univ Johns Hopkins Ultrasound-detectable markers, ultrasound system, and methods for monitoring vascular flow and patency
CN105073022A (en) * 2013-03-15 2015-11-18 德维克医疗产品公司 Biopsy site marker applier
JP5840329B2 (en) * 2013-11-06 2016-01-06 オリンパス株式会社 Device for body fluid collection
CA2985498A1 (en) * 2015-07-16 2017-01-19 Sonavex, Inc. Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity

Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2192270A (en) * 1938-05-25 1940-03-05 American Brake Co Brake rigging
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
US3818894A (en) * 1971-01-22 1974-06-25 Ceskoslovenska Akademie Ved Laryngeal implant
US3823212A (en) * 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US4007732A (en) * 1975-09-02 1977-02-15 Robert Carl Kvavle Method for location and removal of soft tissue in human biopsy operations
US4172449A (en) * 1978-05-01 1979-10-30 New Research And Development Laboratories, Inc. Body fluid pressure monitor
US4197846A (en) * 1974-10-09 1980-04-15 Louis Bucalo Method for structure for situating in a living body agents for treating the body
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4390018A (en) * 1980-09-15 1983-06-28 Zukowski Henry J Method for preventing loss of spinal fluid after spinal tap
US4545367A (en) * 1982-07-16 1985-10-08 Cordis Corporation Detachable balloon catheter and method of use
US4647480A (en) * 1983-07-25 1987-03-03 Amchem Products, Inc. Use of additive in aqueous cure of autodeposited coatings
US4693237A (en) * 1986-01-21 1987-09-15 Hoffman Richard B Radiopaque coded ring markers for use in identifying surgical grafts
US4813062A (en) * 1986-08-13 1989-03-14 Milliken Research Corporation Radio-opaque marker and method
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US4847049A (en) * 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
US4863470A (en) * 1985-03-19 1989-09-05 Medical Engineering Corporation Identification marker for a breast prosthesis
US4889707A (en) * 1988-01-29 1989-12-26 The Curators Of The University Of Missouri Composition and method for radiation synovectomy of arthritic joints
US4909250A (en) * 1988-11-14 1990-03-20 Smith Joseph R Implant system for animal identification
US5081997A (en) * 1989-03-09 1992-01-21 Vance Products Incorporated Echogenic devices, material and method
US5137928A (en) * 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5147307A (en) * 1991-06-17 1992-09-15 Gluck Seymour M Anatomical marker device and method
US5221269A (en) * 1990-10-15 1993-06-22 Cook Incorporated Guide for localizing a nonpalpable breast lesion
US5236410A (en) * 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
US5281197A (en) * 1992-07-27 1994-01-25 Symbiosis Corporation Endoscopic hemostatic agent delivery system
US5281408A (en) * 1991-04-05 1994-01-25 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5282781A (en) * 1990-10-25 1994-02-01 Omnitron International Inc. Source wire for localized radiation treatment of tumors
US5289831A (en) * 1989-03-09 1994-03-01 Vance Products Incorporated Surface-treated stent, catheter, cannula, and the like
US5334381A (en) * 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5368030A (en) * 1992-09-09 1994-11-29 Izi Corporation Non-invasive multi-modality radiographic surface markers
US5394875A (en) * 1993-10-21 1995-03-07 Lewis; Judith T. Automatic ultrasonic localization of targets implanted in a portion of the anatomy
US5395319A (en) * 1991-03-06 1995-03-07 Suddeutsche Feinmechanik Gmbh Needle for inserting an object into the body
US5422730A (en) * 1994-03-25 1995-06-06 Barlow; Clyde H. Automated optical detection of tissue perfusion by microspheres
US5433204A (en) * 1993-11-16 1995-07-18 Camilla Olson Method of assessing placentation
US5451408A (en) * 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
US5469847A (en) * 1992-09-09 1995-11-28 Izi Corporation Radiographic multi-modality skin markers
US5494030A (en) * 1993-08-12 1996-02-27 Trustees Of Dartmouth College Apparatus and methodology for determining oxygen in biological systems
US5538726A (en) * 1992-02-28 1996-07-23 Order; Stanley E. Method and compositions for delivering cytotoxic agents to cancer
US5549560A (en) * 1992-05-13 1996-08-27 Wijdeven Gijsbertus G P Van De Apparatus and method for injecting a pharmaceutical preparation in solid form
US5580568A (en) * 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5636255A (en) * 1996-03-05 1997-06-03 Queen's University At Kingston Method and apparatus for CT image registration
US5643246A (en) * 1995-02-24 1997-07-01 Gel Sciences, Inc. Electromagnetically triggered, responsive gel based drug delivery device
US5646146A (en) * 1993-02-02 1997-07-08 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5667767A (en) * 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
US5676925A (en) * 1992-03-06 1997-10-14 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
US5676146A (en) * 1996-09-13 1997-10-14 Osteotech, Inc. Surgical implant containing a resorbable radiopaque marker and method of locating such within a body
US5688490A (en) * 1991-02-15 1997-11-18 Bracco International B.V. Mucoadhesive compositions for increasing the ultrasonic image contrast of the digestive tract
US5695480A (en) * 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
US5782775A (en) * 1995-10-20 1998-07-21 United States Surgical Corporation Apparatus and method for localizing and removing tissue
US5823198A (en) * 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5853366A (en) * 1996-07-08 1998-12-29 Kelsey, Inc. Marker element for interstitial treatment and localizing device and method using same
US5902310A (en) * 1996-08-12 1999-05-11 Ethicon Endo-Surgery, Inc. Apparatus and method for marking tissue
US5942209A (en) * 1996-03-11 1999-08-24 Focal, Inc. Method of local radiotherapy by polymerizing a material in vivo to form a hydrogel
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6056700A (en) * 1998-10-13 2000-05-02 Emx, Inc. Biopsy marker assembly and method of use
US6071301A (en) * 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6183497B1 (en) * 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
US6228055B1 (en) * 1994-09-16 2001-05-08 Ethicon Endo-Surgery, Inc. Devices for marking and defining particular locations in body tissue
US6231615B1 (en) * 1997-10-14 2001-05-15 Parallax Medical, Inc. Enhanced visibility materials for implantation in hard tissue
US6234177B1 (en) * 1999-08-12 2001-05-22 Thomas Barsch Apparatus and method for deploying an expandable biopsy marker
US20010003791A1 (en) * 1999-02-02 2001-06-14 Heller Ehrman White & Mcauliffe Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
US6270464B1 (en) * 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US6316522B1 (en) * 1997-08-18 2001-11-13 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
US6336904B1 (en) * 1998-04-07 2002-01-08 Pro Duct Health, Inc. Methods and devices for the localization of lesions in solid tissue
US6356782B1 (en) * 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US20020052572A1 (en) * 2000-09-25 2002-05-02 Kenneth Franco Resorbable anastomosis stents and plugs and their use in patients
US6394965B1 (en) * 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
US6427081B1 (en) * 1999-02-02 2002-07-30 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6450937B1 (en) * 1999-12-17 2002-09-17 C. R. Bard, Inc. Needle for implanting brachytherapy seeds
US6537193B1 (en) * 1998-06-17 2003-03-25 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US6540981B2 (en) * 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US20030116806A1 (en) * 1999-02-18 2003-06-26 Oki Electric Industry Co., Ltd. Input protection circuit connected to protection circuit power source potential line
US6766186B1 (en) * 1999-06-16 2004-07-20 C. R. Bard, Inc. Post biospy tissue marker and method of use
US20040193044A1 (en) * 1999-02-02 2004-09-30 Senorx, Inc. Tissue site markers for in vivo imaging
US20040236211A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Marker or filler forming fluid
US20040236212A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US20040233101A1 (en) * 2003-05-23 2004-11-25 Kim Jin-Woong Method for providing location information in mobile communication system
US6862470B2 (en) * 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US20050065453A1 (en) * 2003-02-24 2005-03-24 Senorx, Inc. Biopsy device with selectable tissue receiving aperture orientation and site illumination
US20050119562A1 (en) * 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands

Family Cites Families (435)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899362A (en) 1959-08-11 Hemostatic sponges and method of
US2481408A (en) 1946-08-13 1949-09-06 Olin Mathieson Regeneration of caustic soda-sodium sulfide cooking liquor
GB708148A (en) 1950-12-18 1954-04-28 Hoechst Ag Hemostatic preparations and process for the manufacture thereof
DE1029528B (en) 1954-01-30 1958-05-08 Med H C Ernst Pohl Dr Apparatus particularly for of marking a borehole to be applied bone screws Knochennaegelund
US2832888A (en) 1956-05-17 1958-04-29 David R Houston Box car detector
US2907327A (en) 1957-02-08 1959-10-06 Pfizer & Co C Pellet implanter
US3005457A (en) 1957-04-01 1961-10-24 Ortho Pharma Corp Methyl cellulose sponge and method of making
US3128744A (en) 1963-01-02 1964-04-14 Keith B Jefferts Method for investigating the migratory habits of macro-organisms
US3516412A (en) 1965-08-16 1970-06-23 Electro Catheter Corp Bipolar electrode having irregularity at inserting end thereof and method of insertion
US3402712A (en) 1966-07-19 1968-09-24 American Home Prod Pellet implanter
US3593343A (en) 1968-07-19 1971-07-20 Robert F Viggers Prosthetic ball-check heart valve
US3757781A (en) 1971-09-17 1973-09-11 R Smart Tool for administering pills to animals
US3820545A (en) 1973-03-26 1974-06-28 K Jefferts Tag implanting machine
US3892731A (en) 1973-11-23 1975-07-01 Univ Delaware Solvents for and purification of chitin
US3921632A (en) 1974-08-16 1975-11-25 Frank M Bardani Implant device
US4005699A (en) 1974-10-09 1977-02-01 Louis Bucalo Methods and apparatus for use in magnetic treatment of the body
US4041931A (en) 1976-05-17 1977-08-16 Elliott Donald P Radiopaque anastomosis marker
US4217889A (en) 1976-09-15 1980-08-19 Heyer-Schulte Corporation Flap development device and method of progressively increasing skin area
US4105030A (en) 1977-01-03 1978-08-08 Syntex (U.S.A.) Inc. Implant apparatus
US4086914A (en) 1977-02-11 1978-05-02 Edwin Bailey Moore Implant injector
US4103690A (en) 1977-03-21 1978-08-01 Cordis Corporation Self-suturing cardiac pacer lead
US4127774A (en) 1977-06-20 1978-11-28 Jerry Gillen X-ray marker
US4588395A (en) 1978-03-10 1986-05-13 Lemelson Jerome H Catheter and method
DE2843963C2 (en) 1978-10-09 1988-02-18 Merck Patent Gmbh, 6100 Darmstadt, De
US4442843A (en) 1980-11-17 1984-04-17 Schering, Ag Microbubble precursors and methods for their production and use
US4470160A (en) 1980-11-21 1984-09-11 Cavon Joseph F Cast gel implantable prosthesis
US4740208A (en) 1980-11-21 1988-04-26 Cavon Joseph F Cast gel implantable prosthesis
US4298998A (en) 1980-12-08 1981-11-10 Naficy Sadeque S Breast prosthesis with biologically absorbable outer container
US4428082A (en) 1980-12-08 1984-01-31 Naficy Sadeque S Breast prosthesis with filling valve
US4487209A (en) 1981-03-16 1984-12-11 Creative Research And Manufacturing Inc. Biopsy needle
US4401124A (en) 1981-08-13 1983-08-30 Technicare Corporation Reflection enhancement of a biopsy needle
US4400170A (en) 1981-09-29 1983-08-23 Syntex (U.S.A.) Inc. Implanting device and implant magazine
US4582061A (en) 1981-11-18 1986-04-15 Indianapolis Center For Advanced Research, Inc. Needle with ultrasonically reflective displacement scale
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4405314A (en) 1982-04-19 1983-09-20 Cook Incorporated Apparatus and method for catheterization permitting use of a smaller gage needle
US4438253A (en) 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
GB2138298B (en) 1983-04-21 1986-11-05 Hundon Forge Ltd Pellet implanter
US4655226A (en) 1983-12-16 1987-04-07 Southland Instruments, Inc. Disposable biopsy needle unit
EP0146699A1 (en) 1983-12-22 1985-07-03 Gebrüder Sulzer Aktiengesellschaft Implanted marker
US4549560A (en) 1984-03-19 1985-10-29 Andis Company Hair curling appliance with elastomer material covering heating element
CA1295796C (en) 1984-03-27 1992-02-18 Conrad Whyne Biodegradable matrix and methods for producing same
US4648880A (en) 1984-08-30 1987-03-10 Daniel Brauman Implantable prosthetic devices
US4963150B1 (en) 1984-08-30 1994-10-04 Daniel Brauman Implantable prosthetic device
US4820267A (en) 1985-02-19 1989-04-11 Endocon, Inc. Cartridge injector for pellet medicaments
US5628781A (en) 1985-06-06 1997-05-13 Thomas Jefferson University Implant materials, methods of treating the surface of implants with microvascular endothelial cells, and the treated implants themselves
US4682606A (en) 1986-02-03 1987-07-28 Decaprio Vincent H Localizing biopsy apparatus
US4661103A (en) 1986-03-03 1987-04-28 Engineering Development Associates, Ltd. Multiple implant injector
US4832680A (en) 1986-07-03 1989-05-23 C.R. Bard, Inc. Apparatus for hypodermically implanting a genitourinary prosthesis
DE3789320T2 (en) 1986-07-30 1994-06-09 Sumitomo Pharma An administration tool for inserting solid medicaments.
US4762128A (en) 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4994028A (en) 1987-03-18 1991-02-19 Endocon, Inc. Injector for inplanting multiple pellet medicaments
US4874376A (en) 1987-04-13 1989-10-17 Hawkins Jr Irvin F Needle guide assembly
US4950234A (en) 1987-05-26 1990-08-21 Sumitomo Pharmaceuticals Company, Limited Device for administering solid preparations
US4989608A (en) 1987-07-02 1991-02-05 Ratner Adam V Device construction and method facilitating magnetic resonance imaging of foreign objects in a body
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US5120802A (en) 1987-12-17 1992-06-09 Allied-Signal Inc. Polycarbonate-based block copolymers and devices
US4870966A (en) 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
EP0327490A1 (en) 1988-02-05 1989-08-09 Schering Aktiengesellschaft Ultrasonic imaging agents, process for their preparation and their diagnostic and therapeutical use
US5425366A (en) 1988-02-05 1995-06-20 Schering Aktiengesellschaft Ultrasonic contrast agents for color Doppler imaging
US4994013A (en) 1988-07-28 1991-02-19 Best Industries, Inc. Pellet for a radioactive seed
US5444113A (en) 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
JPH0545458Y2 (en) 1988-10-25 1993-11-19
US4950665A (en) 1988-10-28 1990-08-21 Oklahoma Medical Research Foundation Phototherapy using methylene blue
JPH02131757A (en) 1988-11-11 1990-05-21 Olympus Optical Co Ltd Cutting implement for surgery
US5800541A (en) 1988-11-21 1998-09-01 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5475052A (en) 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
WO1990009152A1 (en) 1989-02-15 1990-08-23 Microtek Medical, Inc. Biocompatible material and prosthesis
US5141748A (en) 1989-02-17 1992-08-25 Hoffmann-La Roche, Inc. Implant drug delivery device
US5201314A (en) 1989-03-09 1993-04-13 Vance Products Incorporated Echogenic devices, material and method
US5025797A (en) 1989-03-29 1991-06-25 Baran Gregory W Automated biopsy instrument
GB2230191B (en) 1989-04-15 1992-04-22 Robert Graham Urie Lesion location device
DE8905585U1 (en) 1989-05-03 1989-06-29 Bosch-Siemens Hausgeraete Gmbh, 8000 Muenchen, De
US5012818A (en) 1989-05-04 1991-05-07 Joishy Suresh K Two in one bone marrow surgical needle
US5197482A (en) 1989-06-15 1993-03-30 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5018530A (en) 1989-06-15 1991-05-28 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5234426A (en) 1989-06-15 1993-08-10 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5284479A (en) 1989-08-30 1994-02-08 N.V. Nederlandsche Apparatenfabriek Nedap Implanter
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5201704A (en) 1989-11-07 1993-04-13 Ray Joel W Method of making and using a hemostatic agent applicator
JPH03158171A (en) 1989-11-17 1991-07-08 Masataka Saito Cap integral type disposal injection needle
US5197846A (en) 1989-12-22 1993-03-30 Hitachi, Ltd. Six-degree-of-freedom articulated robot mechanism and assembling and working apparatus using same
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
GB9003821D0 (en) 1990-02-20 1990-04-18 Danbiosyst Uk Diagnostic aid
JPH042372U (en) 1990-04-23 1992-01-09
DE69104264T3 (en) 1990-05-18 2002-06-13 Bracco Int Bv filled with gas or air polymeric microcapsules used in the form of suspensions in liquid media for ultrasonic echography.
US5374261A (en) 1990-07-24 1994-12-20 Yoon; Inbae Multifunctional devices for use in endoscopic surgical procedures and methods-therefor
DE69120177T2 (en) 1990-09-10 1996-10-10 Synthes Ag Membrane for bone regeneration
US5353804A (en) 1990-09-18 1994-10-11 Peb Biopsy Corporation Method and device for percutaneous exisional breast biopsy
US6325789B1 (en) 1990-12-27 2001-12-04 Datascope Investment Corporation Device and method for sealing puncture wounds
US5391183A (en) * 1990-09-21 1995-02-21 Datascope Investment Corp Device and method sealing puncture wounds
US5108421A (en) 1990-10-01 1992-04-28 Quinton Instrument Company Insertion assembly and method of inserting a vessel plug into the body of a patient
US6347240B1 (en) 1990-10-19 2002-02-12 St. Louis University System and method for use in displaying images of a body part
US5147295A (en) 1991-01-23 1992-09-15 Ideal Instruments, Inc. Retractable implanter
US5280788A (en) 1991-02-26 1994-01-25 Massachusetts Institute Of Technology Devices and methods for optical diagnosis of tissue
GB9106673D0 (en) 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
JP3007903B2 (en) 1991-03-29 2000-02-14 京セラ株式会社 Artificial disc
US5147631A (en) 1991-04-30 1992-09-15 Du Pont Merck Pharmaceutical Company Porous inorganic ultrasound contrast agents
US5354623A (en) 1991-05-21 1994-10-11 Cook Incorporated Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal
US5242759A (en) 1991-05-21 1993-09-07 Cook Incorporated Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal
US5449560A (en) 1991-07-05 1995-09-12 Dow Corning S.A. Composition suitable for glass laminate interlayer and laminate made therefrom
JPH06511481A (en) 1991-07-05 1994-12-22
US5195540A (en) 1991-08-12 1993-03-23 Samuel Shiber Lesion marking process
US5199441A (en) 1991-08-20 1993-04-06 Hogle Hugh H Fine needle aspiration biopsy apparatus and method
NL9101489A (en) 1991-09-03 1993-04-01 Texas Instruments Holland Injector for hypodermically implanting an object into a living being.
US5320100A (en) 1991-09-16 1994-06-14 Atrium Medical Corporation Implantable prosthetic device having integral patency diagnostic indicia
US5344640A (en) 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging
US5290310A (en) 1991-10-30 1994-03-01 Howmedica, Inc. Hemostatic implant introducer
US5358514A (en) 1991-12-18 1994-10-25 Alfred E. Mann Foundation For Scientific Research Implantable microdevice with self-attaching electrodes
GB9200391D0 (en) 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
FR2686499A1 (en) 1992-01-28 1993-07-30 Technomed Int Sa An apparatus for processing a target, such as a lesion within the body of a mammal, especially a human being, using a marker element implanted in or adjacent the target to control the therapy of said target.
EP0627942B1 (en) 1992-03-06 1999-09-15 Nycomed Imaging As Improvements in or relating to contrast agents
CA2131024A1 (en) 1992-03-06 1993-09-16 Arsalan Kharazmi Treatment and prophylaxis of diseases caused by parasites, or bacteria
US6350274B1 (en) 1992-05-11 2002-02-26 Regen Biologics, Inc. Soft tissue closure systems
US5250026A (en) 1992-05-27 1993-10-05 Destron/Idi, Inc. Adjustable precision transponder injector
US5366756A (en) 1992-06-15 1994-11-22 United States Surgical Corporation Method for treating bioabsorbable implant material
US5851461A (en) 1992-06-19 1998-12-22 Albany International Research Co. Method of producing polysaccharide foams
US5542915A (en) 1992-08-12 1996-08-06 Vidamed, Inc. Thermal mapping catheter with ultrasound probe
US5460182A (en) 1992-09-14 1995-10-24 Sextant Medical Corporation Tissue penetrating apparatus and methods
US5334216A (en) 1992-12-10 1994-08-02 Howmedica Inc. Hemostatic plug
US5320613A (en) 1993-01-06 1994-06-14 Scimed Life Systems, Inc. Medical lumen flushing and guide wire loading device and method
JPH08505771A (en) 1993-01-12 1996-06-25 ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン Growth and differentiation factor -3
EP0636015A4 (en) 1993-01-19 1995-08-02 Hang Fu Lee Apparatus and method for implant prostheses.
US5799099A (en) 1993-02-12 1998-08-25 George S. Allen Automatic technique for localizing externally attached fiducial markers in volume images of the head
US5551429A (en) 1993-02-12 1996-09-03 Fitzpatrick; J. Michael Method for relating the data of an image space to physical space
DE4306277C2 (en) 1993-03-01 2000-11-02 Leibinger Gmbh Operation marking tool
US5362478A (en) 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5405402A (en) 1993-04-14 1995-04-11 Intermedics Orthopedics, Inc. Implantable prosthesis with radiographic marker
US5388588A (en) 1993-05-04 1995-02-14 Nabai; Hossein Biopsy wound closure device and method
US5312435A (en) 1993-05-17 1994-05-17 Kensey Nash Corporation Fail predictable, reinforced anchor for hemostatic puncture closure
US5490521A (en) 1993-08-31 1996-02-13 Medtronic, Inc. Ultrasound biopsy needle
US5409004A (en) 1993-06-11 1995-04-25 Cook Incorporated Localization device with radiopaque markings
US5994341A (en) 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
US6159445A (en) 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
US5431639A (en) 1993-08-12 1995-07-11 Boston Scientific Corporation Treating wounds caused by medical procedures
US5676698A (en) 1993-09-07 1997-10-14 Datascope Investment Corp. Soft tissue implant
US5360416A (en) 1993-09-30 1994-11-01 Sherwood Medical Company Thin-walled anesthesia needles
US5545180A (en) 1993-12-13 1996-08-13 Ethicon, Inc. Umbrella-shaped suture anchor device with actuating ring member
US5728122A (en) 1994-01-18 1998-03-17 Datascope Investment Corp. Guide wire with releaseable barb anchor
US5626611A (en) 1994-02-10 1997-05-06 United States Surgical Corporation Composite bioabsorbable materials and surgical articles made therefrom
US5928773A (en) 1994-02-15 1999-07-27 Vitric Corporation Foamed glass articles and methods of making same and methods of controlling the pH of same within specific limits
US5507807A (en) 1994-03-01 1996-04-16 Shippert; Ronald D. Apparatus for the release of a substance within a patient
US5417708A (en) 1994-03-09 1995-05-23 Cook Incorporated Intravascular treatment system and percutaneous release mechanism therefor
US20010038087A1 (en) * 1994-06-06 2001-11-08 Hadronic Press, Inc. New chemical species of a magnecule
US5451406A (en) 1994-07-14 1995-09-19 Advanced Uroscience, Inc. Tissue injectable composition and method of use
EP1009317A4 (en) 1997-08-28 2001-01-24 Boston Scient Corp System for implanting a cross-linked polysaccharide fiber and methods of forming and inserting the fiber
US5954670A (en) 1994-10-05 1999-09-21 Baker; Gary H. Mandrel-guided tandem multiple channel biopsy guide device and method of use
US5645146A (en) * 1994-11-08 1997-07-08 Airway Industries, Inc. Suitcase with retractable pull handle
US5891558A (en) 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5632432A (en) 1994-12-19 1997-05-27 Ethicon Endo-Surgery, Inc. Surgical instrument
US5499989A (en) 1994-12-22 1996-03-19 Labash; Stephen S. Breast biopsy apparatus and method of use
WO1996022123A1 (en) 1995-01-18 1996-07-25 Medchem Products, Inc. Apparatus and method for applying a hemostatic agent onto a tissue
US5657366A (en) 1995-02-23 1997-08-12 Nakayama; Masanari Film markers for specifying body postures of animal photographed in roentgenograms
FR2731343B1 (en) 1995-03-08 1997-08-22 De La Joliniere Jean H Bouquet A suspicious lesions Locating the breast and apparatus for its implementation
US5795308A (en) 1995-03-09 1998-08-18 Russin; Lincoln D. Apparatus for coaxial breast biopsy
US5817022A (en) 1995-03-28 1998-10-06 Sonometrics Corporation System for displaying a 2-D ultrasound image within a 3-D viewing environment
US6135993A (en) 1995-04-17 2000-10-24 Hussman; Karl L. Optical localization fiber
US5782771A (en) 1995-04-17 1998-07-21 Hussman; Karl L. Dual, fused, and grooved optical localization fibers
US6120536A (en) 1995-04-19 2000-09-19 Schneider (Usa) Inc. Medical devices with long term non-thrombogenic coatings
GB2301362B (en) 1995-05-30 1999-01-06 Johnson & Johnson Medical Absorbable implant materials having controlled porosity
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US5779647A (en) 1995-06-07 1998-07-14 Chau; Sonny Automated biopsy instruments
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US5817034A (en) 1995-09-08 1998-10-06 United States Surgical Corporation Apparatus and method for removing tissue
US5611352A (en) 1995-09-14 1997-03-18 Kobren; Myles S. Cervical biopsy device
JPH11513577A (en) 1995-10-13 1999-11-24 トランスバスキュラー インコーポレイテッド Apparatus for tissue between transluminal intervention, the system and method
DE69633411D1 (en) 1995-10-13 2004-10-21 Transvascular Inc A device for avoidance of arterial constrictions and / or to perform other interventions transvaskularer
CA2187975C (en) 1995-10-20 2001-05-01 Lisa W. Heaton Surgical apparatus and method for marking tissue location
US5800445A (en) 1995-10-20 1998-09-01 United States Surgical Corporation Tissue tagging device
US5782764A (en) 1995-11-07 1998-07-21 Iti Medical Technologies, Inc. Fiber composite invasive medical instruments and methods for use in interventional imaging procedures
US5702682A (en) 1995-12-01 1997-12-30 Hercules Incorporated Methods for preparing radiopaque medical devices
US5769086A (en) 1995-12-06 1998-06-23 Biopsys Medical, Inc. Control system and method for automated biopsy device
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US5800389A (en) 1996-02-09 1998-09-01 Emx, Inc. Biopsy device
US6203524B1 (en) 1997-02-10 2001-03-20 Emx, Inc. Surgical and pharmaceutical site access guide and methods
US5842477A (en) 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US5747060A (en) 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5821184A (en) 1996-03-29 1998-10-13 Andrew Ungerleider Foamed glass article for preparing surfaces, use therefor, and method of making same
US5865806A (en) 1996-04-04 1999-02-02 Becton Dickinson And Company One step catheter advancement automatic needle retraction system
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5669882A (en) 1996-04-23 1997-09-23 Pyles; Stephen Curved epidural needle system
US7236816B2 (en) 1996-04-25 2007-06-26 Johns Hopkins University Biopsy and sampling needle antennas for magnetic resonance imaging-guided biopsies
US5846220A (en) 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US6530896B1 (en) 1996-05-13 2003-03-11 James B. Elliott Apparatus and method for introducing an implant
US5690120A (en) 1996-05-24 1997-11-25 Sarcos, Inc. Hybrid catheter guide wire apparatus
US5820918A (en) 1996-07-11 1998-10-13 Hercules Incorporated Medical devices containing in-situ generated medical compounds
US5702128A (en) 1996-07-18 1997-12-30 Beekley Corporation Radiographic marker system and method of making same
US5842999A (en) 1996-07-31 1998-12-01 C.R. Bard, Inc. Automated tissue sampling device
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US5824081A (en) 1996-09-13 1998-10-20 Lipomatrix Incorporated Hydraulic foam tissue implant
US20020058882A1 (en) 1998-06-22 2002-05-16 Artemis Medical, Incorporated Biopsy localization method and device
US6166079A (en) 1996-09-25 2000-12-26 Board Of Regents, The University Of Texas System DFMO for the treatment or prevention of cervical intraepithelial neoplasia
US5830178A (en) 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
US6264917B1 (en) 1996-10-28 2001-07-24 Nycomed Imaging As Targeted ultrasound contrast agents
US5845646A (en) 1996-11-05 1998-12-08 Lemelson; Jerome System and method for treating select tissue in a living being
US6106473A (en) 1996-11-06 2000-08-22 Sts Biopolymers, Inc. Echogenic coatings
US6660010B2 (en) 1998-01-27 2003-12-09 Scimed Life Systems, Inc. Bone anchor placement device with recessed anchor mount
US6119031A (en) 1996-11-21 2000-09-12 Boston Scientific Corporation Miniature spectrometer
US5897507A (en) 1996-11-25 1999-04-27 Symbiosis Corporation Biopsy forceps instrument having irrigation and aspiration capabilities
US5976146A (en) 1997-07-11 1999-11-02 Olympus Optical Co., Ltd. Surgical operation system and method of securing working space for surgical operation in body
US5876340A (en) 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US5941439A (en) 1997-05-14 1999-08-24 Mitek Surgical Products, Inc. Applicator and method for deploying a surgical fastener in tissue
US5876457A (en) 1997-05-20 1999-03-02 George J. Picha Spinal implant
JP2002503991A (en) 1997-06-13 2002-02-05 マイクロ・テラピューティクス・インコーポレーテッド Shape new syringes and luer hub and vascular embolization method
GB9712525D0 (en) 1997-06-16 1997-08-20 Nycomed Imaging As Method
US6306154B1 (en) 1997-06-18 2001-10-23 Bhk Holding Hemostatic system for body cavities
DE19731021A1 (en) 1997-07-18 1999-01-21 Meyer Joerg In vivo degradable metallic implant
US6096037A (en) 1997-07-29 2000-08-01 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
US5980564A (en) 1997-08-01 1999-11-09 Schneider (Usa) Inc. Bioabsorbable implantable endoprosthesis with reservoir
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6340367B1 (en) 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
US6090996A (en) * 1997-08-04 2000-07-18 Collagen Matrix, Inc. Implant matrix
EP1003422B1 (en) 1997-08-05 2006-06-14 Boston Scientific Limited Detachable aneurysm neck bridge
US5854382A (en) 1997-08-18 1998-12-29 Meadox Medicals, Inc. Bioresorbable compositions for implantable prostheses
US6616630B1 (en) 1997-08-20 2003-09-09 B. Braun Melsungen A.G. Spring clip safety IV catheter
US7125397B2 (en) 1997-08-20 2006-10-24 B. Braun Melsungen Ag Protective device for an injection needle
US6117108A (en) 1997-08-20 2000-09-12 Braun Melsungen Ag Spring clip safety IV catheter
US6551253B2 (en) 1997-09-12 2003-04-22 Imagyn Medical Technologies Incisional breast biopsy device
US6142955A (en) 1997-09-19 2000-11-07 United States Surgical Corporation Biopsy apparatus and method
US6096065A (en) 1997-09-29 2000-08-01 Boston Scientific Corporation Sheath for tissue spectroscopy
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8288745B2 (en) 1997-10-10 2012-10-16 Senorx, Inc. Method of utilizing an implant for targeting external beam radiation
US6638308B2 (en) 1997-10-10 2003-10-28 John D. Corbitt, Jr. Bioabsorbable breast implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
JP2001519203A (en) 1997-10-10 2001-10-23 ジョン・ディ・コービット・ジュニア Breast implant
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US6419621B1 (en) 1997-10-24 2002-07-16 Radiomed Corporation Coiled brachytherapy device
US6030333A (en) 1997-10-24 2000-02-29 Radiomed Corporation Implantable radiotherapy device
WO1999021584A1 (en) 1997-10-24 1999-05-06 Children's Medical Center Corporation METHODS FOR PROMOTING CELL TRANSFECTION $i(IN VIVO)
ES2238544T3 (en) 1997-12-29 2005-09-01 Alza Corporation Kit for implant insertion.
DE69937286D1 (en) 1998-01-14 2007-11-22 Leonard Reiffel Arrangement for stabilizing body-internal radiation collecting surfaces
US6181960B1 (en) * 1998-01-15 2001-01-30 University Of Virginia Patent Foundation Biopsy marker device
US6289229B1 (en) 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
US6053925A (en) 1998-02-27 2000-04-25 Barnhart; William H. Lesion localization device and method
US6638234B2 (en) 1998-03-03 2003-10-28 Senorx, Inc. Sentinel node location and biopsy
US6471700B1 (en) 1998-04-08 2002-10-29 Senorx, Inc. Apparatus and method for accessing biopsy site
US6312429B1 (en) 1998-09-01 2001-11-06 Senorx, Inc. Electrosurgical lesion location device
US6540693B2 (en) 1998-03-03 2003-04-01 Senorx, Inc. Methods and apparatus for securing medical instruments to desired locations in a patients body
US7261735B2 (en) 2001-05-07 2007-08-28 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
US6447527B1 (en) 1998-04-23 2002-09-10 Ronald J. Thompson Apparatus and methods for the penetration of tissue
US6162192A (en) 1998-05-01 2000-12-19 Sub Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6610026B2 (en) 1998-05-01 2003-08-26 Sub-Q, Inc. Method of hydrating a sponge material for delivery to a body
US20010045575A1 (en) 1998-05-01 2001-11-29 Mark Ashby Device and method for facilitating hemostasis of a biopsy tract
US6363940B1 (en) 1998-05-14 2002-04-02 Calypso Medical Technologies, Inc. System and method for bracketing and removing tissue
US6224630B1 (en) 1998-05-29 2001-05-01 Advanced Bio Surfaces, Inc. Implantable tissue repair device
EP0966979B1 (en) 1998-06-25 2006-03-08 Biotronik AG Implantable bioresorbable support for the vascular walls, in particular coronary stent
US5941890A (en) 1998-06-26 1999-08-24 Ethicon Endo-Surgery, Inc. Implantable surgical marker
US6261302B1 (en) 1998-06-26 2001-07-17 Ethicon Endo-Surgery, Inc. Applier for implantable surgical marker
US6241734B1 (en) 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone
US5921933A (en) 1998-08-17 1999-07-13 Medtronic, Inc. Medical devices with echogenic coatings
US6179860B1 (en) 1998-08-19 2001-01-30 Artemis Medical, Inc. Target tissue localization device and method
CA2340251C (en) 1998-08-21 2005-01-04 Providence Health System-Oregon Insertable stent and methods of making and using same
US6335029B1 (en) 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6159240A (en) 1998-08-31 2000-12-12 Medtronic, Inc. Rigid annuloplasty device that becomes compliant after implantation
US6951564B2 (en) 1998-10-23 2005-10-04 United States Surgical Corporation Site marker device
US6656192B2 (en) 1998-09-25 2003-12-02 United States Surgical Corporatioin Site marker device
DE69931006T2 (en) 1998-10-14 2007-01-04 Terumo K.K. Wire-shaped radiation source and catheter assembly for radiation
US6220248B1 (en) 1998-10-21 2001-04-24 Ethicon Endo-Surgery, Inc. Method for implanting a biopsy marker
WO2000023124A9 (en) 1998-10-22 2000-08-24 Edwards Lifesciences Corp Multi-functional coatings for medical devices
WO2000024332A1 (en) 1998-10-23 2000-05-04 Cortese Armand F Marker for indicating the location of identified tissue
US7844319B2 (en) 1998-11-04 2010-11-30 Susil Robert C Systems and methods for magnetic-resonance-guided interventional procedures
WO2000028554A1 (en) 1998-11-06 2000-05-18 Nycomed Amersham Plc Products and methods for brachytherapy
US6451871B1 (en) 1998-11-25 2002-09-17 Novartis Ag Methods of modifying surface characteristics
WO2001008578A1 (en) 1999-07-30 2001-02-08 Vivant Medical, Inc. Device and method for safe location and marking of a cavity and sentinel lymph nodes
US6270472B1 (en) 1998-12-29 2001-08-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Apparatus and a method for automatically introducing implants into soft tissue with adjustable spacing
CA2775170C (en) * 2000-11-20 2017-09-05 Senorx, Inc. An intracorporeal marker delivery system for marking a tissue site
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US6482143B1 (en) 1999-02-28 2002-11-19 Syntheon, Llc Raidoactive therapeutic seed having selective marker configuration
US6173715B1 (en) 1999-03-01 2001-01-16 Lucent Medical Systems, Inc. Magnetic anatomical marker and method of use
US6203507B1 (en) 1999-03-03 2001-03-20 Cordis Webster, Inc. Deflectable catheter with ergonomic handle
US6144875A (en) 1999-03-16 2000-11-07 Accuray Incorporated Apparatus and method for compensating for respiratory and patient motion during treatment
WO2000061668A1 (en) 1999-04-09 2000-10-19 The Regents Of The University Of Michigan Preparing porous hydrogel products
GB9909801D0 (en) 1999-04-28 1999-06-23 Btg Int Ltd Ultrasound detectable instrument
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US20060247665A1 (en) 1999-05-28 2006-11-02 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
DE60037731T2 (en) 1999-06-05 2009-01-15 Wilson-Cook Medical Inc. Markers for a medical endoscopic device
US6066122A (en) 1999-06-09 2000-05-23 Fisher; John Needle apparatus and method for marking lesions
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
US6626899B2 (en) 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
US6200258B1 (en) 1999-08-10 2001-03-13 Syntheon, Llc Radioactive therapeutic seed having selective marker configuration
US6250307B1 (en) 1999-09-17 2001-06-26 Pi Medical, Inc. Snoring treatment
JP2001161838A (en) 1999-12-07 2001-06-19 Yuichiro Asano Wire-like radiation source member for cancer treatment and feeding device of the same
US6899731B2 (en) 1999-12-30 2005-05-31 Boston Scientific Scimed, Inc. Controlled delivery of therapeutic agents by insertable medical devices
EP1114618A3 (en) 2000-01-04 2001-08-22 Ethicon Endo-Surgery, Inc. Surgical instrument for applying beads to tissue
US6506156B1 (en) 2000-01-19 2003-01-14 Vascular Control Systems, Inc Echogenic coating
US6575888B2 (en) 2000-01-25 2003-06-10 Biosurface Engineering Technologies, Inc. Bioabsorbable brachytherapy device
US6488693B2 (en) 2000-01-26 2002-12-03 Hearport, Inc. Vascular incisor and method
US6358217B1 (en) 2000-01-31 2002-03-19 Hugh Bourassa Automatic and semi-automatic disposable biopsy needle device
US6436030B2 (en) 2000-01-31 2002-08-20 Om P. Rehil Hiatal hernia repair patch and method for using the same
US6564806B1 (en) 2000-02-18 2003-05-20 Thomas J. Fogarty Device for accurately marking tissue
EP1259155B1 (en) 2000-02-18 2010-12-08 Fogarty, Thomas J. Improved device for accurately marking tissue
US6241687B1 (en) 2000-02-18 2001-06-05 Ethicon Endo-Surgery, Inc. Method of use for a biopsy instrument with breakable sample segments
US6350244B1 (en) 2000-02-21 2002-02-26 Biopsy Sciences, Llc Bioabsorable markers for use in biopsy procedures
US6770070B1 (en) 2000-03-17 2004-08-03 Rita Medical Systems, Inc. Lung treatment apparatus and method
US6450938B1 (en) 2000-03-21 2002-09-17 Promex, Llc Brachytherapy device
US6356112B1 (en) 2000-03-28 2002-03-12 Translogic Technology, Inc. Exclusive or/nor circuit
US6628982B1 (en) 2000-03-30 2003-09-30 The Regents Of The University Of Michigan Internal marker device for identification of biological substances
WO2001074251A3 (en) 2000-03-31 2002-01-31 Daniel J Balbierz Tissue biopsy and treatment apparatus and method
US6425903B1 (en) 2000-05-09 2002-07-30 James W. Voegele Implantable surgical marker
US7419678B2 (en) 2000-05-12 2008-09-02 Cordis Corporation Coated medical devices for the prevention and treatment of vascular disease
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
WO2001089484A3 (en) 2000-05-22 2002-07-04 Duane Glover Method for increasing the compressibility of poorly binding powder materials
US6544231B1 (en) 2000-05-22 2003-04-08 Medcanica, Inc. Catch, stop and marker assembly for a medical instrument and medical instrument incorporating the same
US6961608B2 (en) 2000-06-05 2005-11-01 Kabushiki Kaisha Toshiba Interventional MR imaging with detection and display of device position
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US6716444B1 (en) 2000-09-28 2004-04-06 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US6746773B2 (en) 2000-09-29 2004-06-08 Ethicon, Inc. Coatings for medical devices
US6712774B2 (en) 2000-10-13 2004-03-30 James W. Voegele Lockout for a surgical biopsy device
US6730044B2 (en) 2000-10-13 2004-05-04 Ethicon Endo-Surgery, Inc. Firing mechanism for use in a surgical biopsy device
US6540694B1 (en) 2000-10-16 2003-04-01 Sanarus Medical, Inc. Device for biopsy tumors
US6447524B1 (en) 2000-10-19 2002-09-10 Ethicon Endo-Surgery, Inc. Fastener for hernia mesh fixation
US6544185B2 (en) * 2000-10-23 2003-04-08 Valentino Montegrande Ultrasound imaging marker and method of use
EP1377342A4 (en) * 2000-10-25 2006-11-29 Gary A Lamoureux Pre-loaded needle assembly
KR20030045847A (en) 2000-10-31 2003-06-11 쿡 인코포레이티드 Coated implantable medical device
US6758824B1 (en) 2000-11-06 2004-07-06 Suros Surgical Systems, Inc. Biopsy apparatus
US6514193B2 (en) 2000-11-16 2003-02-04 Microspherix Llc Method of administering a therapeutically active substance
US20020077687A1 (en) 2000-12-14 2002-06-20 Ahn Samuel S. Catheter assembly for treating ischemic tissue
US20020077693A1 (en) 2000-12-19 2002-06-20 Barclay Bruce J. Covered, coiled drug delivery stent and method
US6478790B2 (en) 2000-12-22 2002-11-12 Frank M. Bardani Implant device and dosage form employable therein
CA2434151C (en) 2001-01-11 2009-12-22 Rita Medical Systems, Inc. Bone-treatment instrument and method
US20020095205A1 (en) 2001-01-12 2002-07-18 Edwin Tarun J. Encapsulated radiopaque markers
US6749627B2 (en) 2001-01-18 2004-06-15 Ev3 Peripheral, Inc. Grip for stent delivery system
US7014610B2 (en) 2001-02-09 2006-03-21 Medtronic, Inc. Echogenic devices and methods of making and using such devices
DE20103363U1 (en) 2001-02-26 2001-05-17 Braun Melsungen Ag Protective device for a hypodermic needle
US8197535B2 (en) 2001-06-19 2012-06-12 Cordis Corporation Low profile improved radiopacity intraluminal medical device
US6863685B2 (en) 2001-03-29 2005-03-08 Cordis Corporation Radiopacity intraluminal medical device
US6636758B2 (en) 2001-05-01 2003-10-21 Concentric Medical, Inc. Marker wire and process for using it
US6824527B2 (en) 2001-06-07 2004-11-30 Peter Gollobin Protective sheath for winged needles and sheath and needle assembly
US6723052B2 (en) 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US7160258B2 (en) 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
US6648849B2 (en) 2001-06-27 2003-11-18 Ethicon, Inc. Medicinal implant and device and method for loading and delivering implants containing drugs and cells
US9861517B2 (en) * 2001-07-26 2018-01-09 Cook Medical Technologies Llc Vessel closure member, delivery apparatus, and method of inserting the member
DE60215819T2 (en) 2001-08-03 2007-09-06 Tyco Healthcare Group Lp, Norwalk Marker tissue marking device for use with a
US6913626B2 (en) 2001-08-14 2005-07-05 Mcghan Jim J. Medical implant having bioabsorbable textured surface
US6605047B2 (en) 2001-09-10 2003-08-12 Vivant Medical, Inc. Biopsy marker delivery system
US7135978B2 (en) 2001-09-14 2006-11-14 Calypso Medical Technologies, Inc. Miniature resonating marker assembly
US7294118B2 (en) 2001-10-24 2007-11-13 Becton, Dickinson And Company Retractable needle assembly
US6939318B2 (en) 2001-12-05 2005-09-06 Boston Scientific Scimed, Inc. Method, tool, and system for deploying an implant into the body
US7280865B2 (en) 2001-12-20 2007-10-09 Accuray Incorporated Anchored fiducial apparatus and method
US8088388B2 (en) 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
WO2003077730A8 (en) 2002-03-11 2004-12-02 John L Wardle Surgical coils and methods of deploying
US7527610B2 (en) 2002-03-29 2009-05-05 Bioform Medical, Inc. Connection indicator for a medical delivery/extraction system
EP1495130A4 (en) 2002-04-03 2006-07-05 Agy Therapeutics Inc Use of biomolecular targets in the treatment and visualization of brain tumors
US20030191355A1 (en) 2002-04-04 2003-10-09 Ferguson Patrick J. Hollow bioabsorbable elements for positioning material in living tissue
US6818668B2 (en) 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
US6652442B2 (en) 2002-04-23 2003-11-25 Acueity, Inc. Micro-endoscope assembly for intraductal brachytherapy of a mammary duct and method of using same
US20030199887A1 (en) 2002-04-23 2003-10-23 David Ferrera Filamentous embolization device and method of use
US7329414B2 (en) 2002-05-03 2008-02-12 Biopsy Sciences, Llc Biodegradable polymer for marking tissue and sealing tracts
US6780179B2 (en) 2002-05-22 2004-08-24 Rubicor Medical, Inc. Methods and systems for in situ tissue marking and orientation stabilization
US6992233B2 (en) 2002-05-31 2006-01-31 Medafor, Inc. Material delivery system
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
EP1521603B1 (en) 2002-07-12 2011-01-19 Cook Incorporated Coated medical device
US20040016195A1 (en) 2002-07-24 2004-01-29 Archuleta John Paul Foamed glass article for use as thermal energy control media
US7670350B2 (en) 2002-08-01 2010-03-02 Selis James E Biopsy devices and methods
WO2004020024A1 (en) 2002-08-30 2004-03-11 Inrad, Inc. Localizing needle with fluid delivery
US7103418B2 (en) 2002-10-02 2006-09-05 Medtronic, Inc. Active fluid delivery catheter
US20040116802A1 (en) 2002-10-05 2004-06-17 Jessop Precision Products, Inc. Medical imaging marker
US8027712B2 (en) 2002-10-11 2011-09-27 Ion Beam Applications S.A. Elongated markers for soft tissue volume identification
US6936014B2 (en) 2002-10-16 2005-08-30 Rubicor Medical, Inc. Devices and methods for performing procedures on a breast
US6994712B1 (en) 2002-11-12 2006-02-07 Biopsy Sciences, Llc Bioabsorbable marker having external anchoring means
DE60331790D1 (en) 2002-11-18 2010-04-29 Bard Peripheral Vascular Inc Device for the introduction of a device for marking and localization of a tissue
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US8137288B2 (en) 2002-11-20 2012-03-20 Boston Scientific Scimed, Inc. Medical instrument
US7008382B2 (en) 2002-11-20 2006-03-07 Scimed Life Systems, Inc. Medical instrument
US20040101548A1 (en) 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Hemostatic wound dressing containing aldehyde-modified polysaccharide
US7247160B2 (en) 2002-12-30 2007-07-24 Calypso Medical Technologies, Inc. Apparatuses and methods for percutaneously implanting objects in patients
US6889833B2 (en) 2002-12-30 2005-05-10 Calypso Medical Technologies, Inc. Packaged systems for implanting markers in a patient and methods for manufacturing and using such systems
US20040133124A1 (en) 2003-01-06 2004-07-08 Cook Incorporated. Flexible biopsy needle
US9314235B2 (en) 2003-02-05 2016-04-19 Smith & Nephew, Inc. Tissue anchor and insertion tool
US7189206B2 (en) 2003-02-24 2007-03-13 Senorx, Inc. Biopsy device with inner cutter
US8157810B2 (en) 2003-02-26 2012-04-17 Cook Medical Technologies Llc Prosthesis adapted for placement under external imaging
FR2853521B1 (en) 2003-04-10 2005-12-02 Claude Mialhe The expander of a vessel and introducer vascular implant
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US7641643B2 (en) 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US7306580B2 (en) 2003-04-16 2007-12-11 Cook Incorporated Medical device with therapeutic agents
DE10318802A1 (en) 2003-04-17 2004-11-04 Aesculap Ag & Co. Kg Self-adhesive absorbable hemostatic
US6945973B2 (en) 2003-05-01 2005-09-20 Nuvasive, Inc. Slidable bone plate system
US7783336B2 (en) 2003-06-06 2010-08-24 Ethicon Endo-Surgery, Inc. Subcutaneous biopsy cavity marker device
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
US7744852B2 (en) 2003-07-25 2010-06-29 Rubicor Medical, Llc Methods and systems for marking post biopsy cavity sites
US7537788B2 (en) 2003-07-25 2009-05-26 Rubicor Medical, Inc. Post-biopsy cavity treatment implants and methods
US20050033157A1 (en) 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
US20050049634A1 (en) 2003-08-07 2005-03-03 Scimed Life Systems, Inc. Medical closure device
US7790141B2 (en) 2003-08-11 2010-09-07 Pathak Holdings, Llc Radio-opaque compounds, compositions containing same and methods of their synthesis and use
US7001341B2 (en) 2003-08-13 2006-02-21 Scimed Life Systems, Inc. Marking biopsy sites
WO2005023323A1 (en) 2003-09-08 2005-03-17 Fmc Biopolymer As Gelled biopolymer based foam
US20050059887A1 (en) 2003-09-16 2005-03-17 Hassan Mostafavi Localization of a target using in vivo markers
WO2005037338A1 (en) 2003-10-14 2005-04-28 Cook Incorporated Hydrophilic coated medical device
EP1691852A2 (en) 2003-11-10 2006-08-23 Angiotech International AG Medical implants and fibrosis-inducing agents
WO2005051232A3 (en) 2003-11-20 2005-12-08 Angiotech Int Ag Soft tissue implants and anti-scarring agents
US20050113659A1 (en) 2003-11-26 2005-05-26 Albert Pothier Device for data input for surgical navigation system
EP1689308A1 (en) 2003-11-26 2006-08-16 Invivo Germany GmbH Tissue marker and method and apparatus for deploying the marker
US7761138B2 (en) 2004-03-12 2010-07-20 Boston Scientific Scimed, Inc. MRI and X-ray visualization
US7901707B2 (en) 2004-03-15 2011-03-08 Christine Allen Biodegradable biocompatible implant and method of manufacturing same
US20050234336A1 (en) 2004-03-26 2005-10-20 Beckman Andrew T Apparatus and method for marking tissue
US9638770B2 (en) 2004-05-21 2017-05-02 Devicor Medical Products, Inc. MRI biopsy apparatus incorporating an imageable penetrating portion
US20060241385A1 (en) 2005-04-12 2006-10-26 Ethicon Endo-Surgery, Inc. Guided disposable fiducial for breast biopsy localization fixture
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US8075568B2 (en) 2004-06-11 2011-12-13 Selis James E Biopsy devices and methods
DE102004030391A1 (en) 2004-06-23 2006-01-26 Somatex Medical Technologies Gmbh marker
WO2006022786A1 (en) 2004-08-20 2006-03-02 David Mullen Tissue marking devices and systems
US20060079805A1 (en) 2004-10-13 2006-04-13 Miller Michael E Site marker visable under multiple modalities
US8280486B2 (en) 2004-10-13 2012-10-02 Suros Surgical Systems, Inc. Site marker visable under multiple modalities
EP1806160A1 (en) 2004-10-22 2007-07-11 Kaneka Corporation Catheter for medical treatment
WO2006056739A3 (en) 2004-11-23 2006-08-24 Anthony James Maxwell Surgical tag, magnetometer, and associated system
WO2006069677A3 (en) 2004-12-30 2006-12-07 Soheil Asgari Combination comprising an agent providing a signal, an implant material and a drug
DE102005012574A1 (en) 2005-03-18 2006-09-21 Bkh - Technotransfer Gmbh Marker for animal and human tissues, especially soft tissue
US20060217635A1 (en) 2005-03-24 2006-09-28 Mccombs Elizabeth S Biopsy device marker deployment
CA2602795A1 (en) 2005-03-31 2006-10-05 Cytyc Corporation Internal biopsy marking
CN101243332A (en) 2005-06-21 2008-08-13 纳维斯堪Pet系统有限公司 Tissue interventions using nuclear-emission image guidance
US20060292690A1 (en) 2005-06-22 2006-12-28 Cesco Bioengineering Co., Ltd. Method of making cell growth surface
US7736293B2 (en) 2005-07-22 2010-06-15 Biocompatibles Uk Limited Implants for use in brachytherapy and other radiation therapy that resist migration and rotation
US9498647B2 (en) 2005-09-23 2016-11-22 Allen B. Kantrowitz Fiducial marker system for subject movement compensation during medical treatment
EP1767167B1 (en) 2005-09-26 2011-05-18 Bard Peripheral Vascular, Inc. Post decompression marker introducer system
US20070083132A1 (en) 2005-10-11 2007-04-12 Sharrow James S Medical device coil
US7761137B2 (en) 2005-12-16 2010-07-20 Suros Surgical Systems, Inc. Biopsy site marker deployment device
EP1988942B1 (en) 2006-03-01 2011-07-27 FMC Biopolymer AS Gelled composite
US8118786B2 (en) 2006-03-29 2012-02-21 Kawasumi Laboratories, Inc. Guarded medical winged needle assembly
US20070287933A1 (en) 2006-06-08 2007-12-13 Chris Phan Tissue debulking device and method of using the same
US20090171198A1 (en) 2006-08-04 2009-07-02 Jones Michael L Powdered marker
US20090216118A1 (en) 2007-07-26 2009-08-27 Senorx, Inc. Polysaccharide markers
EP2109409A4 (en) 2006-12-12 2012-11-21 Bard Inc C R Multiple imaging mode tissue marker
US20080177179A1 (en) 2006-12-19 2008-07-24 Cytyc Corporation Target Tissue Locator for Image Guided Radiotherapy
US20090024225A1 (en) 2007-07-16 2009-01-22 Stubbs James B Implant for Targeting Therapeutic Procedure
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US7978825B2 (en) 2008-10-13 2011-07-12 Mdx Laboratories, Llc Anatomical marker for x-ray orientation
CA2742765C (en) 2008-12-30 2016-04-12 C.R. Bard Inc. Marker delivery device for tissue marker placement

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2192270A (en) * 1938-05-25 1940-03-05 American Brake Co Brake rigging
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
US3823212A (en) * 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US3818894A (en) * 1971-01-22 1974-06-25 Ceskoslovenska Akademie Ved Laryngeal implant
US4197846A (en) * 1974-10-09 1980-04-15 Louis Bucalo Method for structure for situating in a living body agents for treating the body
US4007732A (en) * 1975-09-02 1977-02-15 Robert Carl Kvavle Method for location and removal of soft tissue in human biopsy operations
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4172449A (en) * 1978-05-01 1979-10-30 New Research And Development Laboratories, Inc. Body fluid pressure monitor
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4390018A (en) * 1980-09-15 1983-06-28 Zukowski Henry J Method for preventing loss of spinal fluid after spinal tap
US4545367A (en) * 1982-07-16 1985-10-08 Cordis Corporation Detachable balloon catheter and method of use
US4647480A (en) * 1983-07-25 1987-03-03 Amchem Products, Inc. Use of additive in aqueous cure of autodeposited coatings
US4863470A (en) * 1985-03-19 1989-09-05 Medical Engineering Corporation Identification marker for a breast prosthesis
US4847049A (en) * 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
US4693237A (en) * 1986-01-21 1987-09-15 Hoffman Richard B Radiopaque coded ring markers for use in identifying surgical grafts
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US4813062A (en) * 1986-08-13 1989-03-14 Milliken Research Corporation Radio-opaque marker and method
US4889707A (en) * 1988-01-29 1989-12-26 The Curators Of The University Of Missouri Composition and method for radiation synovectomy of arthritic joints
US4909250A (en) * 1988-11-14 1990-03-20 Smith Joseph R Implant system for animal identification
US5081997A (en) * 1989-03-09 1992-01-21 Vance Products Incorporated Echogenic devices, material and method
US5289831A (en) * 1989-03-09 1994-03-01 Vance Products Incorporated Surface-treated stent, catheter, cannula, and the like
US5334381A (en) * 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5137928A (en) * 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5236410A (en) * 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
US5221269A (en) * 1990-10-15 1993-06-22 Cook Incorporated Guide for localizing a nonpalpable breast lesion
US5282781A (en) * 1990-10-25 1994-02-01 Omnitron International Inc. Source wire for localized radiation treatment of tumors
US5688490A (en) * 1991-02-15 1997-11-18 Bracco International B.V. Mucoadhesive compositions for increasing the ultrasonic image contrast of the digestive tract
US5395319A (en) * 1991-03-06 1995-03-07 Suddeutsche Feinmechanik Gmbh Needle for inserting an object into the body
US5281408A (en) * 1991-04-05 1994-01-25 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5147307A (en) * 1991-06-17 1992-09-15 Gluck Seymour M Anatomical marker device and method
US5538726A (en) * 1992-02-28 1996-07-23 Order; Stanley E. Method and compositions for delivering cytotoxic agents to cancer
US5676925A (en) * 1992-03-06 1997-10-14 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
US5549560A (en) * 1992-05-13 1996-08-27 Wijdeven Gijsbertus G P Van De Apparatus and method for injecting a pharmaceutical preparation in solid form
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5281197A (en) * 1992-07-27 1994-01-25 Symbiosis Corporation Endoscopic hemostatic agent delivery system
US5469847A (en) * 1992-09-09 1995-11-28 Izi Corporation Radiographic multi-modality skin markers
US5368030A (en) * 1992-09-09 1994-11-29 Izi Corporation Non-invasive multi-modality radiographic surface markers
US5646146A (en) * 1993-02-02 1997-07-08 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5494030A (en) * 1993-08-12 1996-02-27 Trustees Of Dartmouth College Apparatus and methodology for determining oxygen in biological systems
US5394875A (en) * 1993-10-21 1995-03-07 Lewis; Judith T. Automatic ultrasonic localization of targets implanted in a portion of the anatomy
US5433204A (en) * 1993-11-16 1995-07-18 Camilla Olson Method of assessing placentation
US5451408A (en) * 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
US5422730A (en) * 1994-03-25 1995-06-06 Barlow; Clyde H. Automated optical detection of tissue perfusion by microspheres
US6228055B1 (en) * 1994-09-16 2001-05-08 Ethicon Endo-Surgery, Inc. Devices for marking and defining particular locations in body tissue
US5643246A (en) * 1995-02-24 1997-07-01 Gel Sciences, Inc. Electromagnetically triggered, responsive gel based drug delivery device
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
US5851508A (en) * 1995-07-27 1998-12-22 Microtherapeutics, Inc. Compositions for use in embolizing blood vessels
US5667767A (en) * 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
US5580568A (en) * 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
US5782775A (en) * 1995-10-20 1998-07-21 United States Surgical Corporation Apparatus and method for localizing and removing tissue
US5636255A (en) * 1996-03-05 1997-06-03 Queen's University At Kingston Method and apparatus for CT image registration
US20010006616A1 (en) * 1996-03-11 2001-07-05 D Leavitt Richard Polymeric delivery of radionuclides and radiopharmaceuticals
US5942209A (en) * 1996-03-11 1999-08-24 Focal, Inc. Method of local radiotherapy by polymerizing a material in vivo to form a hydrogel
US5853366A (en) * 1996-07-08 1998-12-29 Kelsey, Inc. Marker element for interstitial treatment and localizing device and method using same
US5695480A (en) * 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US5823198A (en) * 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5902310A (en) * 1996-08-12 1999-05-11 Ethicon Endo-Surgery, Inc. Apparatus and method for marking tissue
US5676146B1 (en) * 1996-09-13 2000-04-18 Osteotech Inc Surgical implant containing a resorbable radiopaque marker and method of locating such within a body
US5676146A (en) * 1996-09-13 1997-10-14 Osteotech, Inc. Surgical implant containing a resorbable radiopaque marker and method of locating such within a body
US6316522B1 (en) * 1997-08-18 2001-11-13 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
US6231615B1 (en) * 1997-10-14 2001-05-15 Parallax Medical, Inc. Enhanced visibility materials for implantation in hard tissue
US6562317B2 (en) * 1997-11-03 2003-05-13 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6214315B1 (en) * 1997-11-03 2001-04-10 Micro Therapeutics Inc Radioactive embolizing compositions
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6540981B2 (en) * 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
US20010033867A1 (en) * 1997-12-18 2001-10-25 Ahern John E. Systems and methods for local delivery of an agent
US6336904B1 (en) * 1998-04-07 2002-01-08 Pro Duct Health, Inc. Methods and devices for the localization of lesions in solid tissue
US6183497B1 (en) * 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
US6071301A (en) * 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6537193B1 (en) * 1998-06-17 2003-03-25 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US6270464B1 (en) * 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US20050045192A1 (en) * 1998-06-22 2005-03-03 Artemis Medical, Inc. Biopsy localization method and device
US6056700A (en) * 1998-10-13 2000-05-02 Emx, Inc. Biopsy marker assembly and method of use
US6356782B1 (en) * 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US20060036159A1 (en) * 1998-12-24 2006-02-16 Sirimanne D L Biopsy cavity marking device
US6347241B2 (en) * 1999-02-02 2002-02-12 Senorx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US6427081B1 (en) * 1999-02-02 2002-07-30 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US20050063908A1 (en) * 1999-02-02 2005-03-24 Senorx, Inc. Tissue site markers for in vivo imaging
US20060036165A1 (en) * 1999-02-02 2006-02-16 Senorx, Inc. Tissue site markers for in vivo imaging
US20050143656A1 (en) * 1999-02-02 2005-06-30 Senorx, Inc. Cavity-filling biopsy site markers
US20010003791A1 (en) * 1999-02-02 2001-06-14 Heller Ehrman White & Mcauliffe Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US6567689B2 (en) * 1999-02-02 2003-05-20 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6862470B2 (en) * 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US20040101479A1 (en) * 1999-02-02 2004-05-27 Senorx, Inc. Biopsy site marker and process and apparatus for applying it
US20020038087A1 (en) * 1999-02-02 2002-03-28 Senorx, Inc. Imageable biopsy site marker
US20040193044A1 (en) * 1999-02-02 2004-09-30 Senorx, Inc. Tissue site markers for in vivo imaging
US20030116806A1 (en) * 1999-02-18 2003-06-26 Oki Electric Industry Co., Ltd. Input protection circuit connected to protection circuit power source potential line
US6766186B1 (en) * 1999-06-16 2004-07-20 C. R. Bard, Inc. Post biospy tissue marker and method of use
US6234177B1 (en) * 1999-08-12 2001-05-22 Thomas Barsch Apparatus and method for deploying an expandable biopsy marker
US6450937B1 (en) * 1999-12-17 2002-09-17 C. R. Bard, Inc. Needle for implanting brachytherapy seeds
US6394965B1 (en) * 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
US20020052572A1 (en) * 2000-09-25 2002-05-02 Kenneth Franco Resorbable anastomosis stents and plugs and their use in patients
US20050065453A1 (en) * 2003-02-24 2005-03-24 Senorx, Inc. Biopsy device with selectable tissue receiving aperture orientation and site illumination
US20040233101A1 (en) * 2003-05-23 2004-11-25 Kim Jin-Woong Method for providing location information in mobile communication system
US20050119562A1 (en) * 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US20040236212A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US20040236211A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Marker or filler forming fluid

Cited By (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US9480554B2 (en) 1997-10-10 2016-11-01 Senorx, Inc. Tissue marking implant
US9039763B2 (en) 1997-10-10 2015-05-26 Senorx, Inc. Tissue marking implant
US20100010342A1 (en) * 1999-02-02 2010-01-14 Senorx, Inc. Tissue site markers for in vivo imaging
US20060036165A1 (en) * 1999-02-02 2006-02-16 Senorx, Inc. Tissue site markers for in vivo imaging
US20060084865A1 (en) * 1999-02-02 2006-04-20 Burbank Fred H Imageable biopsy site marker
US8626270B2 (en) 1999-02-02 2014-01-07 Senorx, Inc. Cavity-filling biopsy site markers
US7792569B2 (en) 1999-02-02 2010-09-07 Senorx, Inc. Cavity-filling biopsy site markers
US8224424B2 (en) 1999-02-02 2012-07-17 Senorx, Inc. Tissue site markers for in vivo imaging
US9649093B2 (en) 1999-02-02 2017-05-16 Senorx, Inc. Cavity-filling biopsy site markers
US8965486B2 (en) 1999-02-02 2015-02-24 Senorx, Inc. Cavity filling biopsy site markers
US20120116215A1 (en) * 1999-02-02 2012-05-10 Jones Michael L Deployment of polysaccharide markers for treating a site within a patient
US20090131825A1 (en) * 1999-02-02 2009-05-21 Senorx, Inc. Imageable biopsy site marker
US9237937B2 (en) 1999-02-02 2016-01-19 Senorx, Inc. Cavity-filling biopsy site markers
US9149341B2 (en) * 1999-02-02 2015-10-06 Senorx, Inc Deployment of polysaccharide markers for treating a site within a patient
US9044162B2 (en) 1999-02-02 2015-06-02 Senorx, Inc. Marker delivery device with releasable plug
US7565191B2 (en) 1999-02-02 2009-07-21 Senorx, Inc. Tissue site markers for in vivo imaging
US8219182B2 (en) 1999-02-02 2012-07-10 Senorx, Inc. Cavity-filling biopsy site markers
US8579931B2 (en) 1999-06-17 2013-11-12 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
US9579159B2 (en) 1999-06-17 2017-02-28 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
US8718745B2 (en) 2000-11-20 2014-05-06 Senorx, Inc. Tissue site markers for in vivo imaging
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US8784433B2 (en) 2002-06-17 2014-07-22 Senorx, Inc. Plugged tip delivery tube for marker placement
US8177792B2 (en) 2002-06-17 2012-05-15 Senorx, Inc. Plugged tip delivery tube for marker placement
US20030233101A1 (en) * 2002-06-17 2003-12-18 Senorx, Inc. Plugged tip delivery tube for marker placement
US8758369B2 (en) 2002-08-01 2014-06-24 James E. Selis Biopsy devices and methods
US20100106168A1 (en) * 2002-08-01 2010-04-29 Selis James E Biopsy devices and methods
US20100130887A1 (en) * 2002-08-01 2010-05-27 Selis James E Biopsy devices and methods
US8414602B2 (en) 2002-08-01 2013-04-09 James E. Selis Biopsy devices and methods
US9848956B2 (en) 2002-11-18 2017-12-26 Bard Peripheral Vascular, Inc. Self-contained, self-piercing, side-expelling marking apparatus
WO2006049911A1 (en) * 2003-05-23 2006-05-11 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US9801688B2 (en) 2003-05-23 2017-10-31 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US20040236212A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US8626269B2 (en) 2003-05-23 2014-01-07 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US8880154B2 (en) 2003-05-23 2014-11-04 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US20050119562A1 (en) * 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US8639315B2 (en) 2003-05-23 2014-01-28 Senorx, Inc. Marker or filler forming fluid
US8447386B2 (en) 2003-05-23 2013-05-21 Senorx, Inc. Marker or filler forming fluid
US8634899B2 (en) 2003-11-17 2014-01-21 Bard Peripheral Vascular, Inc. Multi mode imaging marker
US8454629B2 (en) 2004-06-11 2013-06-04 James E. Selis Biopsy devices and methods
US20050277871A1 (en) * 2004-06-11 2005-12-15 Selis James E Biopsy devices and methods
US20100292711A2 (en) * 2004-06-11 2010-11-18 James Selis Biopsy devices and methods
US20100145363A1 (en) * 2004-06-11 2010-06-10 Selis James E Biopsy devices and methods
US8075568B2 (en) 2004-06-11 2011-12-13 Selis James E Biopsy devices and methods
US8075569B2 (en) 2004-06-11 2011-12-13 Selis James E Biopsy devices and methods
US8198588B2 (en) 2004-08-12 2012-06-12 Navotek Medical Ltd. Localization of a radioactive source within a body of a subject
US8239002B2 (en) 2004-08-12 2012-08-07 Novatek Medical Ltd. Guiding a tool for medical treatment by detecting a source of radioactivity
US20070055090A1 (en) * 2004-08-12 2007-03-08 Navotek Medical Ltd. Medical Treatment System and Method
US8198600B2 (en) 2004-08-12 2012-06-12 Navotek Medical Ltd. Localization of a radioactive source
US7952079B2 (en) 2004-08-12 2011-05-31 Navotek Medical Ltd. Localization of a radioactive source
US8164064B2 (en) 2004-08-12 2012-04-24 Navotek Medical Ltd. Localization of a radioactive source within a body of a subject
US20090127459A1 (en) * 2004-08-12 2009-05-21 Navotek Medical Ltd. Localization of a Radioactive Source
US20080262473A1 (en) * 2004-10-19 2008-10-23 Navotek Medical Ltd. Locating a Catheter Tip Using a Tracked Guide
US8486028B2 (en) 2005-10-07 2013-07-16 Bard Peripheral Vascular, Inc. Tissue marking apparatus having drug-eluting tissue marker
US20080234532A1 (en) * 2005-10-22 2008-09-25 Invibio Limited Fiducial marker
US7702378B2 (en) 2005-11-17 2010-04-20 Breast-Med, Inc. Tissue marker for multimodality radiographic imaging
US8544162B2 (en) 2005-11-17 2013-10-01 Breast-Med, Inc. Tissue marker for multimodality radiographic imaging
US9241773B2 (en) 2005-11-17 2016-01-26 Breast-Med, Inc. Imaging fiducial markers and methods
US20070110665A1 (en) * 2005-11-17 2007-05-17 Bolan Patrick J Tissue marker for multimodality radiographic imaging
US9861450B2 (en) 2005-11-17 2018-01-09 Breast-Med, Inc. Imaging fiducial markers and methods
US8966735B2 (en) 2005-11-17 2015-03-03 Breast-Med, Inc. Tissue marker for multimodality radiographic imaging
US20090171199A1 (en) * 2006-02-03 2009-07-02 Anders Widmark Method and instrument as well as use of instrument for permanent application of reference marker for precision aiming of treatment beam
US20090131734A1 (en) * 2006-02-16 2009-05-21 Navotek Medical Ltd. Implantable medical marker and methods of preparation thereof
US20090171198A1 (en) * 2006-08-04 2009-07-02 Jones Michael L Powdered marker
US20110184449A1 (en) * 2006-08-04 2011-07-28 Senorx, Inc. Marker delivery device with obturator
US8437834B2 (en) 2006-10-23 2013-05-07 C. R. Bard, Inc. Breast marker
US20130123829A1 (en) * 2006-11-24 2013-05-16 Senorx, Inc. Mri detectable obturator
US9579077B2 (en) 2006-12-12 2017-02-28 C.R. Bard, Inc. Multiple imaging mode tissue marker
US8401622B2 (en) 2006-12-18 2013-03-19 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
US9042965B2 (en) 2006-12-18 2015-05-26 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
US9622822B2 (en) 2007-05-01 2017-04-18 Suros Surgical Systems, Inc. Securement for a surgical site marker and deployment device for same
US20080287729A1 (en) * 2007-05-16 2008-11-20 Anthony Biscotti Interstitial marker and method for creation thereof
US8311610B2 (en) 2008-01-31 2012-11-13 C. R. Bard, Inc. Biopsy tissue marker
US8068895B2 (en) 2008-02-25 2011-11-29 Devicor Medical Products, Inc. Biopsy site marker deployment instrument
US20090216150A1 (en) * 2008-02-25 2009-08-27 Lee Reichel Method and Apparatus For Inserting Biopsy Site Marker In Marker Body
US8079964B2 (en) 2008-02-25 2011-12-20 Devicor Medical Products, Inc. Method and apparatus for inserting biopsy site marker in marker body
US20090216181A1 (en) * 2008-02-25 2009-08-27 Speeg Trevor W V Biopsy Site Marker Deployment Instrument
EP2156806A1 (en) 2008-08-18 2010-02-24 Navotek Medical Ltd. Implantation device for soft tissue markers and other implants
US7942843B2 (en) 2008-08-18 2011-05-17 Navotek Medical Ltd. Implantation device for soft tissue markers and other implants
US20100042041A1 (en) * 2008-08-18 2010-02-18 Navotek Medical Ltd. Implantation device for soft tissue markers and other implants
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US8670818B2 (en) 2008-12-30 2014-03-11 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US20100280367A1 (en) * 2009-04-30 2010-11-04 Ducharme Richard W System and method for fiducial deployment
US9042964B2 (en) 2009-04-30 2015-05-26 Cook Medical Technologies Llc System and method for fiducial deployment via slotted needle
US20110071424A1 (en) * 2009-09-22 2011-03-24 Nock Andrew P Biopsy marker delivery device
US8371443B2 (en) * 2009-09-22 2013-02-12 Devicor Medical Products, Inc. Biopsy marker delivery device
US9427186B2 (en) 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
US9522264B2 (en) 2013-02-26 2016-12-20 Cook Medical Technologies Llc Ratchet-slide handle and system for fiducial deployment
US9808539B2 (en) 2013-03-11 2017-11-07 Endomagnetics Ltd. Hypoosmotic solutions for lymph node detection
US9523748B2 (en) 2013-03-13 2016-12-20 Endomagnetics Ltd Magnetic detector
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
US9770262B2 (en) 2014-06-09 2017-09-26 Cook Medical Technologies Llc Screw-driven handles and systems for fiducial deployment
US9795455B2 (en) 2014-08-22 2017-10-24 Breast-Med, Inc. Tissue marker for multimodality radiographic imaging

Also Published As

Publication number Publication date Type
EP1626667B1 (en) 2015-12-02 grant
US20040236212A1 (en) 2004-11-25 application
WO2004105626A2 (en) 2004-12-09 application
US20090018439A1 (en) 2009-01-15 application
WO2004105626A3 (en) 2005-05-12 application
EP1626667A2 (en) 2006-02-22 application
US20150051477A1 (en) 2015-02-19 application
JP2006528907A (en) 2006-12-28 application
US7983734B2 (en) 2011-07-19 grant
CA2526592A1 (en) 2004-12-09 application
US20110237943A1 (en) 2011-09-29 application
US9801688B2 (en) 2017-10-31 grant
ES2561390T3 (en) 2016-02-25 grant
US7970454B2 (en) 2011-06-28 grant
EP2550927A1 (en) 2013-01-30 application
US8626269B2 (en) 2014-01-07 grant
US20130310686A1 (en) 2013-11-21 application
US8880154B2 (en) 2014-11-04 grant
CA2526592C (en) 2013-10-29 grant

Similar Documents

Publication Publication Date Title
Liberman et al. Clip placement after stereotactic vacuum-assisted breast biopsy.
US5409004A (en) Localization device with radiopaque markings
US6425903B1 (en) Implantable surgical marker
US5941890A (en) Implantable surgical marker
US20010047169A1 (en) Surgical biopsy device
US20090000629A1 (en) Elastically Deformable Marker
US20090270725A1 (en) Devices Useful In Imaging
US5396897A (en) Method for locating tumors prior to needle biopsy
US6540693B2 (en) Methods and apparatus for securing medical instruments to desired locations in a patients body
US6183497B1 (en) Absorbable sponge with contrasting agent
US7479152B2 (en) Target tissue localization device
US20030097079A1 (en) Biopsy needle sheath
US6993375B2 (en) Tissue site markers for in vivo imaging
Heywang-Köbrunner et al. MR-guided percutaneous excisional and incisional biopsy of breast lesions
US20060173280A1 (en) Multi Mode Imaging Marker
US6220248B1 (en) Method for implanting a biopsy marker
US5902310A (en) Apparatus and method for marking tissue
EP0829232A2 (en) Minimally invasive biopsy device
US7169114B2 (en) Biopsy and delivery device
US6056700A (en) Biopsy marker assembly and method of use
US6862470B2 (en) Cavity-filling biopsy site markers
US5111828A (en) Device for percutaneous excisional breast biopsy
US6228055B1 (en) Devices for marking and defining particular locations in body tissue
US20060173296A1 (en) Site marker visable under multiple modalities
US6350244B1 (en) Bioabsorable markers for use in biopsy procedures

Legal Events

Date Code Title Description
AS Assignment

Owner name: SENORX, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JONES, MICHAEL L.;LUBOCK, PAUL;MERRITT, JOHN;REEL/FRAME:015502/0497

Effective date: 20040304